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Due to the inability of intra-articular injuries to adequately self-heal, current therapies are 
largely focused on palliative care and restoration of joint function rather than true 
regeneration.  Subsequently tissue engineering of chondral and osteochondral tissue 
constructs has emerged as a promising strategy for the repair of partial and full-thickness 
intra-articular defects.  Unfortunately, the fabrication of large tissue constructs is plagued 
by poor nutrient transport to the interior of the tissue resulting in poor tissue growth and 
necrosis.  Further, for the specific case of osteochondral grafts, the presence of two distinct 
tissue types offers additional challenges related to cell sourcing, scaffolding strategies, and 
bioprocessing. To overcome these constraints, this dissertation was focused on the 
development and validation of a microfluidic hydrogel platform which reduces nutrient 
transport limitations within an engineered tissue construct through a serpentine 
microfluidic network embedded within the developing tissue.  To this end, a microfluidic 
hydrogel was designed to meet the nutrition requirements of a developing tissue and 
validated through the cultivation of chondral tissue constructs of clinically relevant 
thicknesses.  Additionally, optimal bioprocessing conditions with respect to morphogen 
delivery and hydrodynamic loading were pursued for the production of bony and 
cartilaginous tissue from bone marrow derived mesenchymal stem cells.  Finally, the 
optimal bioprocessing conditions were implemented within MSC laden microfluidic 
hydrogels to spatially engineer the matrix composition of a biphasic osteochondral graft 










Articular Cartilage is a resilient load-bearing soft tissue which covers the ends of bones in 
synovial joints.  It receives its functional properties from its large avascular, alymphatic, 
and aneural extracellular matrix primarily made up of collagens, proteoglycans, and water.  
The solid phase of the matrix (collagens and proteoglycans) provides the tissue with its 
strength to resist tensile and shearing loads, while the interaction of the proteoglycans with 
water in the matrix interstitial gives the tissue its resistance to compressive loads and 
durability.  The avascular and alymphatic nature of the tissue, however, limit the tissue’s 
ability to repair itself in the event of an acute traumatic insult.  Further, severe intra-
articular injuries can also impact the subchondral bone.  Injuries which penetrate to the 
subchondral bone may result in filling of the defect with a suboptimal fibrocartilage 
resulting from the migration and differentiation of bone marrow progenitor cells.  These 
sites subsequently result in a high reoccurrence of injury and progressive degeneration 
through a process coined post-traumatic osteoarthritis.  As standard treatment of intra-
articular defects are palliative in nature and do not offer true regeneration of the articular 
surface, novel therapeutic strategies are sought to combat these injuries through restoration 
of the biological and physical functions of the osteochondral unit. 
 
 Research Objectives 
Tissue engineering has emerged as a promising strategy for the repair partial and full-
thickness osteochondral defects.  In order for engineered constructs to be clinically relevant 
functional criteria such as size, structure, mechanical properties, biochemical composition, 
immunological compatibility and integration capability must be met.  Great strides toward 
meeting these criteria have been made such that the scientific community can now produce 
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constructs which approach the metrics of the native tissue for most of these criteria.  The 
processes which produce such constructs, however, are limited in their ability to produce 
constructs which are simultaneously mechanically robust, adequately nourished, and of 
clinically relevant thickness. 
 
Therefore, the overall goal of my dissertation was to develop and utilize a microfluidic 
hydrogel culture system which reduces nutrient transport limitations within engineered 
tissues and allows the delivery of biochemical and physical cues to modulate cell fate 
processes for the purpose of chondral and osteochondral defect repair.  I approached this 
problem by addressing the following specific aims: 
 
Specific Aim I: Parametric Design of Microfluidic Hydrogel Network for Optimal 
Nutrient Utilization in Tissue Engineering Constructs   
Embedding a microfluidic network within the bulk of hydrogel based tissue engineering 
constructs offer the ability to spatiotemporally manipulate the physical and biochemical 
microenvironment of the resident cell population.  To maximize the metabolic activity of 
the developing tissue, the design parameters of microfluidic network and culture conditions 
should be well characterized and controlled.  The objective of this study is to design of the 
microfluidic network with regard to the number, size and spacing of channels, as well the 
material properties of the hydrogel, flow profile, and the seeding density of the cell source 
all impact the distribution and utilization of nutrients, wastes, and chemical signaling 
molecules in the tissue.  Through the use of finite-element modeling and literature 
benchmarks an optimal microfludic hydrogel will be established for articular cartilage 
engineering.  Our design will be validated by showing that our prototype produces tissue 
constructs which exhibit increased cell viability and proliferation, increased deposition of 
extracellular matrix components (collagen II, proteoglycans), and improved histological 
grading relative to static controls with and without embedded channels. 
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Specific Aim II:  Determine the Effect of Hydrodynamic Loading on Chondrogenic 
and Osteogenic Differentiation of Mesenchymal Stem Cells 
Mesenchymal Stems Cells (MSCs) are well known progenitor cells for both the 
chondrocyte and osteoblast lineages.  The differentiation path can be modulated both by 
the composition of the media in which the MSCs are cultured, and by the physical 
environment in which the cells reside.  The objective of this study, therefore, was to 
determine the effect of uniform superficial shear stress on the differentiation of bovine 
mesenchymal stems cells down the chondrogenic and osteogenic lineages. Specific Aim I 
provides a range of flow rates which provide for the homogeneous distribution of metabolic 
solutes (glucose, oxygen, growth factors) throughout the construct.  Within this operating 
range, the flow rate was varied to elucidate the relationship between the magnitude and 
duration of the applied stress and the expression of chondrogenic and osteogenic markers.  
Additionally, cultures supplemented with inductive cytokines were assessed under static 
and dynamic loading conditions to elucidate synergistic effects of chemical 
supplementation and physical stimulation for the purpose of optimizing culture conditions 
for MSC differentiation.  The working hypothesis of this study was that osteogenic 
differentiation will require exposure to a higher shear rate than chondrogenic 
differentiation. 
 
Specific Aim III:  Spatially Engineer Osteochondral Tissue Constructs Through 
Microfluidically Directed Differentiation of Mesenchymal Stem Cells 
The objective of this study was to induce differential expression of chondrogenic and 
osteogenic markers within a continuous hydrogel construct for repairing osteochondral 
defects.  Integrated osteochondral constructs with a differential phenotypic character were 
produced by incorporating independent, parallel flow structures into the bulk of the tissue 
construct and supplying optimized media and bioprocessing conditions differentially 
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within the two flow structures.  The working hypothesis of this study was that the 
expression chondrogenic and osteogenic differentiation markers will vary according to 
spatial proximity to the microfluidic network doped with the appropriate induction cues. 
 Significance & Scientific Impact 
The technological advancement and studies described herein have broad implications in 
the area of tissue engineering beyond the present application of chondral and osteochondral 
tissue engineering.  It is not difficult to imagine extension of the technique to tissues of 
multiple cell types including vascularized tissues, tumorogenesis models, and interfacial 
tissue engineering (bone/tendon, bone/ligament, bone cartilage) as well as investigational 
drug and stem cell differentiation studies.  The ability to expand the thickness of constructs 
produced in a high-throughput manner also opens the possibility of our technique being an 
enabling technology for the fulfillment cost-efficient, readily available tissue engineered 




 The Osteochondral Unit 
The osteochondral unit is an apparent level organization of two distinct tissue types:  the 
articular cartilage which provides a smooth wear resistant surface at the articulating 
junctions of diarthrodial joints and the subchondral trabecular bone.  Between these two 
tissues, the mechanical and chemical makeup of the tissue varies in composition (Figure 
2.1).   
 
 
Figure 2.1:  Illustration of Osteochondral Unit 
The osteochondral unit consists of articular cartilage separated from a region of trabecular 
bone by a region of calcified cartilage.  Image adapted from Buckwalter, J., Mow, V., et al. 
(1994). "Restoration of Injured or Degenerated Articular Cartilage." Journal of the American 
Academy of Orthopaedic Surgeons 2(4): 192-201. 
 
Described herein are the structure, composition, and function of these tissue that make 
them unique and are of the greatest importance when considering the rational design of a 
tissue engineered replacement. 
2.1.1 Articular Cartilage Structure & Function 
2.1.1.1 Tissue Composition 
Articular cartilage is a white, dense, connective tissue, from 1 to 5 mm thick, that covering 
the ends of diarthrodial joints (Mow et al. 1984).  It is composed of two distinct phases:  a 
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solid organic phase consisting of cells and extracellular matrix, and an aqueous phase 
which fills the interstitial space of the matrix.  The structure and composition of the solid 
phase varies in terms of cell shape and arrangement, proteoglycan concentration, and 
collagen fiber diameter and orientation as a function of distance from the articular surface.  
Close to the surface, thin collagen fibrils surround elongated chondrocytes and are oriented 
parallel to the surface.  The proteoglycan content in this region, in low and the water content 
high largely due to its proximity to the synovium.  Below this superficial region, exists a 
transitional region containing collagen fibers of a larger diameter lacking apparent 
organization, and chondrocytes of a more rounded morphology.  Deeper still, the 
composition of the extracellular matrix increases in proteoglycan content, and contains a 
high concentration of large diameter collagen fibrils oriented perpendicularly to the 
articular surface.  Chondrocytes in this region are typically arranged in a columnar fashion.  
Beyond this deep zone, there exists a region of calcified cartilage which is adjacent to the 
subchondral bone and characterized by small cells populating a cartilaginous matrix 
incorporating apatitic salts. 
2.1.1.1.1 Chondrocytes 
Chondrocytes are the specialized cells, derived from mesenchymal stem cells during 
skeletal morphogenesis, on which the formation of articular cartilage is dependent.    They 
are the sole cell type present in mature articular cartilage and are highly sparse in 
distribution representing only 5% to 10% of the total cartilage volume (Hunziker et al. 
2002).  While metabolically active and responsive to various environmental stimuli, 
including soluble cytokines and changes in mechanical loading (Buckwalter 1997), they 
are non-migratory and non-proliferative under normal physiology and subsequently offer 
little regenerative capacity in the event of traumatic injury.  Their primary function in their 
mature state is the turnover of cartilaginous matrix macromolecules in a state of dynamic 
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equilibrium between the cellular environment and the structure of the tissue (Lin et al. 
2006). 
2.1.1.1.2 Extracellular Matrix 
The extracellular matrix of articular cartilage is comprised of two principal classes of 









Figure 2.2:  Illustration of Cartilaginous Matrix Components 
The cartilaginous matrix is primarily made up of type II collagen fibrils and proteoglycans 
such as hyaluronic acid.  Filling the interstitial space between these components is an 
aqueous fluid phase.  Image adapted from Buckwalter, J., Mow, V., et al. (1994). "Restoration 
of Injured or Degenerated Articular Cartilage." Journal of the American Academy of 
Orthopaedic Surgeons 2(4): 192-201. 
 
Other biomolecules including lipids, phospholipids, and non-collagenous proteins, and 
make up the remaining portion of the ECM.  Among collagen types II, VI, IX, X, and XI, 
type II collagen is the most abundant accounting for 90-95% of the collagen in hyaline 
cartilaginous matrix (Temenoff and Mikos 2000).  The collagenous portion of the matrix 
generally consists of thin fibrils in a cross-linked network lacking organization with the 
exception of the superficial layer in which fibrils align parallel to the articular surface and 
in the deep zone where fibrillar arrangement perpendicular to the articulating surface 
promotes anchoring of the cartilage to the subchondral bone.  In addition to imparting the 
tensile properties of the tissue, the collagen network also serves to control of the loss of 
fluid through the cartilage, and to encapsulate the other major constituent of the ECM, the 
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proteoglycans (Buckwalter and Mankin 1998; Cohen et al. 1998).  Proteoglycans are 
complex macromolecules consisting of a protein core with covalently bound 
glycosaminoglycan chains.  Glycosaminoglycans are long unbranched polysaccharides 
containing repeating carboxyl and/or sulfate groups which become ionized rendering them 
highly hydrophilic and promoting matrix hydration and resilience to compressive loads. 
2.1.1.1.3 Water 
Accounting for up to 80% of the wet weight of the tissue (Temenoff and Mikos 2000), 
water plays a critical role in the structure and function of articular cartilage.  Water fills the 
intrafibrillar space of the collagenous matrix and associates with the negative charges on 
the glycosaminoglycan chains of the proteoglycan complexes to support the matrix under 
high compressive loads due to its incompressibility.  The water is largely free to move 
through the matrix under the influence of a pressure gradient.  As the water contains 
dissolved salts, gases, and metabolites this movement of water and exchange with the fluid 
of the synovium serves as the primary means of nutrient transport to the avascular tissue. 
2.1.1.2 Tissue Mechanics 
As previously discussed, articular cartilage is a biphasic material consisting of the solid 
components of the extracellular matrix and the aqueous fluid which fills its void space and 
it free to move through the tissue.  It is this unique combination of tensile elements 
(collagens) and compressive strength through fluid pressurization that impart upon the 
tissue its viscoelastic mechanical properties and make it exceptionally wear resistant and 
absorbent of shocking deformations.  Under compressive loading, the observed 
viscoelasticity is primarily due to drag as a result of interstitial flow of synovial fluid 
through the molecular pore space.  Under shearing loads, the observed viscoelasticity is 
independent of fluid flow and largely due to straightening of the collagen fibers, friction 
between adjacent fibers, and the breaking of intermolecular bonds as is typical of most 
polymers. 
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2.1.2 Subchondral Bone Structure & Function 
Subchondral bone refers to the cortical endplate and trabecular bone lying just below the 
calcified zone of the articular surface. Architecturally, it is composed of a branching lattice 
of internal beams and plates aligned along areas of mechanical stress.  This region also 
contains a significant population blood vessels and nerves which can extend into the 
calcified cartilage.  Physiologically, subchondral bone serves multiple functions including 
calcium homeostasis and housing bone marrow which serves as the production site of 
hematopoietic and mesenchymal precursors.  Structurally, the synergy of the molecular, 
cellular, and tissue arrangement results in a strong yet light weight structural tissue, which 
serves as an anchoring and structural support for articular cartilage.  
2.1.2.1 Tissue Composition 
2.1.2.1.1 Bone Cells 
There are three principal cell types present in bone:  osteoblasts, osteocytes, and 
osteoclasts. Osteoblasts are the cells responsible for the formation of bone through the 
production of type I collagen, osteocalcin, and bone sialoprotein and other less abundant 
bone proteins.  Osteocytes are former osteoblasts that have become encased in a 
mineralized matrix.  Osteocytes exhibit long processes that are able to extend through the 
bone’s canaliculi to establish cell-to-cell contact with adjacent cells.  For this reason, 
osteocytes are believed to play a mechanosensory role in bone metabolism and calcium 
exchange.  At the other end of the spectrum are osteoclasts, the cells responsible for the 
resorption of bone through production of acid phosphatases.  They are derived from the 
same hematopoietic precursors of monocytes and macrophages. 
2.1.2.1.2 Extracellular Matrix 
The composition of bony matrix consists of two solid phases of which approximately 60-
70% is inorganic in nature with the remainder consisting of collagen and other organic 
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molecules (Biltz and Pellegrino 1969; Fritsch et al. 2009; Lees 2003; Vuong and Hellmich 
2011). The matrix takes on the form of an interpenetrating mesh with strength in both 
tension and compression due to the organic and inorganic phases respectively.  The 
inorganic component of bone is principally composed of a calcium phosphate mineral 
analogous to crystalline calcium hydroxyapatite, which is deposited by osteoblasts.  These 
deposits act as a both a reservoir for ion homeostasis and as a dopant to increase the 
compressive strength of the tissue.  The organic phase is primarily type I collagen and plays 
a significant role in determining the structure and the mechanical properties of the bone. 
Collagen type I owes its strength to structure in the form of a triple helix of three alpha 
chains stabilized by hydrogen bonding.  This structure makes collagen an excellent tension 
element, particularly when bundled.  The remaining portion of the organic matrix consists 
osteopontin, bone sialoprotein, and growth factors responsible for maintenance of bone 
structure.  
2.1.2.2 Tissue Mechanics 
Bone is an interesting structural material in that it can modulate its properties and geometry 
at the microscopic level in order to accommodate changes in metabolic demand and 
mechanical loading at the macroscopic level.  This is particularly true for trabecular bone 
for which large spatiotemporal variations in density are observed due to age and the amount 
of load a particular anatomic site typically bears.    In general, the apparent modulus of 
trabecular bone can vary from approximately 10 MPa to 2,000 MPa, depending on the 
anatomic site and age (Morgan et al. 2003).  These variations in trabecular density also 
result in significantly different behaviors under tensile loads relative to compressive 
loading.  Under tension, the failure mode is significantly different as individual trabeculae 
will tend to fracture in areas of highly concentrated stress.  This is important as failure 
under compression in not likely to have an effect at the organ level, whereas tensile failure 
could lead to fracture propagation across large swaths of the bone. 
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 Intra-Articular Injury & Treatment 
The average human knee experiences approximately one million cycles of loading each 
year.  In the event that an injury compromises the function of a synovial joint, damage to 
the articular surface often occurs either through direct insult or as a result of incongruities 
and abnormal loading (Buckwalter 1992; Buckwalter 2002).  This damage may take the 
form of fissures, flaps, and tears, which are permanent in nature due to the lack of 
regenerative capacity inherent in articular cartilage.  Injuries which penetrate to the 
subchondral bone may result in filling of the defect with a suboptimal fibrocartilage 
resulting from the migration and differentiation of bone marrow progenitor cells.  These 
sites subsequently result in a high reoccurrence of injury and progressive degeneration 
through a process coined post-traumatic osteoarthritis. 
2.2.1 Post-Traumatic Osteoarthritis 
If allowed to progress unabated, a degenerative condition coined post-traumatic 
osteoarthritis (PTOA) may become symptomatic within three months of the initial injury 
(Buckwalter 1992; Buckwalter and Brown 2004; James et al. 2004; Nelson et al. 2006).  
Because articular cartilage lacks a sufficient self-repair mechanism, the injury site becomes 
a nucleating center for the progressive degeneration (Figure 2.3) of the articular surface 
due to incongruities and unnatural loading regimes which if left unchecked, could lead to 
osteoarthritis and the associated chronic, debilitating pain and swelling (Buckwalter 1992; 
Buckwalter 2002; Buckwalter and Brown 2004; Buckwalter and Mankin 1998; Nelson et 
al. 2006).   
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Figure 2.3:  Etiology & Incidence of PTOA 
PTOA arises from incongruities of the articular surface and abnormal loading conditions 
following traumatic injury, and results in treatment expenditures representing 10% of total 
arthritis related expenditures in the United States. This image was modified and adapted 
from www.maitrise-orthop.com. 
 
While older patients with crippling OA often can be treated effectively with joint 
replacement or joint fusion, these approaches are not as acceptable or effective for the 
young and middle-aged adults which PTOA most commonly afflicts. For this reason, 
younger patients with PTOA present an especially difficult clinical problem.  Thus, new 
therapeutic approaches aimed at regenerating the articular cartilage surface with respect to 
biological and mechanical function are sought, which might prevent the onset of PTOA, 
and mitigate the future physical and medical costs associated with end-stage osteoarthritis 
(OA). 
2.2.2 Standard of Care 
Due to the inability of intra-articular injuries to adequately self-heal, current therapies are 
largely focused on alleviation of symptoms and restoration of joint function rather than true 
regeneration.  Non-surgical treatments, suitable for partial thickness defects, include 
pharmacological treatment of inflammation and viscosupplementation therapies based on 
the injection of hyaluronate based materials.  The long-term efficacy of such approaches, 
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however, is poor.  Full-thickness osteochondral defects are generally too severe for these 
types of treatments to have any significant benefit and generally require surgical 
intervention.  The least invasive procedures include lavage and debridement which can be 
performed arthroscopically and consist of the removal of irritating debris and the 
contouring of the articular surfaces to minimize unnatural loading due to geometric 
incongruities.  Like pharmacologic interventions and viscosupplementation protocols, 
these procedures are palliative in nature, and may still result in degenerative changes within 
the joint, particularly in the long-term.  The first set of more efficient repair techniques 
consists of stimulation of the bone marrow within the subchondral bone.  This is 
accomplished by drilling, abrasion or microfracture techniques and results in filling of the 
defect by migration of MSCs (Simon and Jackson 2006). This approach, however, is 
suboptimal as the repair tissue secreted by the MSCs exhibits fibrocartilaginous 
characteristics including inferior mechanical properties to the surrounding native tissue 
resulting in the repair site remaining a nucleating center for degeneration within 1-2 years.  
 
The other category of reparative procedures includes the implantation of a graft.  
Autologous transplantation techniques require sourcing the patient’s own healthy tissue for 
grafting material to be placed into the defect site. The mosaicplasty or OATS 
(osteochondral autologous transfer system) procedure is one such technique in which the 
defect is cleaned up through debridement and multiple individual osteochondral biopsies 
are harvested from an adjacent, non-load bearing region and press fit into the defect 




Figure 2.4:  Overview of Osteochondral Repair Procedures 
The mosaicplasty procedure is an autologous grafting technique used to treat osteochondral 
lesions through the transplantation of healthy, native tissue to the defect site from an 
adjacent, non-load bearing region.  This image was modified and adapted from 
www.maitrise-orthop.com. 
 
This technique represents a suitable reparative approach, but carries with it a high risk for 
donor-site morbidity.  Another similar approach involves the transplantation of 
allogenically sourced grafts inserted into the defect in a similar manner.  While this 
approach eliminates the donor site morbidity associated with mosaicplasty, it carries with 
it immunological risks that may result in transmission of disease or the rejection of the 
donor tissue.   
 
Autologous Chondrocyte Implantation (ACI) is yet another similar approach to 
mosaicplasty in that it uses autologous material from a non-load bearing site.  It differs, 
however, in that the biopsied tissue is digested and the patient’s cells are expanded in 
culture before reintroduction into the defect underneath a flap fashioned from the patient’s 
periosteum.  Finally, non-biological approaches include total knee replacement via 
condylectomy and insertion of a metallic implant.  Because this prosthesis is only typically 
viable for just over a decade, such a drastic procedure is reserved for patients over the age 
of 65, and typically not recommended for younger patients.  Additionally, the materials 
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these implants are construct from poorly simulate the physiological and mechanical 
functions of native tissues, often resulting in disrupted gait. 
 Tissue Engineering 
2.3.1 General Approach 
Tissue engineering is an interdisciplinary field that draws from concepts of the traditional 
engineering disciplines and life sciences and is focused on the development of biological 
substitutes for the repair and restoration of tissue function in the event of injury or disease.   
Subsequently, tissue engineering & regenerative medicine as complementary fields have 
the potential to transform the landscape of current treatment strategies for severe physical 
injuries and to provide a better quality of life for the patient population.  The classical 
approach to tissue engineering involves the incorporation of a suitable cell source into a 
biodegradable scaffold within which the resident cells synthesis an extracellular matrix 
under the influence of mechanical and chemical signals within the controlled environment 
of a bioreactor system.  To understand tissue engineering as a field and identify areas for 
innovation in the case of osteochondral regeneration, it is paramount to understand the role 
of each of the members of this triad and how they interact to produce an osteochondral 
tissue construct. 
2.3.1.1 Cell Sourcing 
The production of an engineered tissue in vitro requires the use of cells to populate the 
tissue construct and produce neotissue through proliferation and matrix elaboration that 
resembles that of the native tissue in both composition and function.  The most common 
cell sources for osteochondral tissue engineering are primary chondrocytes and osteoblasts 
as wells as their common progenitor, mesenchymal stem cells (Martin et al. 2007).  
Autologous chondrocytes must be harvested from a non-load bearing donor site, and as a 
result suffer from the additional clinical symptoms of donor site morbidity (Huntley et al. 
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2005).  Additionally, the harvest procedure is generally low yield necessitating the in vitro 
expansion of the primary cells prior to incorporation into a tissue engineered graft 
(Brittberg et al. 1994; Huntley et al. 2005; Mats 2008).  The low availability of these cells 
represents a significant challenge to any large scale manufacturing process of engineered 
constructs as a limited life span, dedifferentiation upon monolayer expansion (Darling and 
Athanasiou 2005), and the high cost of maintaining these cells in culture become 
prohibitive.  With these challenges in mind, mesenchymal stem cells (MSCs), whose 
availability, multi-potentiality, and expanded lifespan make them commercially enticing, 
are seen as a promising alternative cell source for regeneration of osteochondral defects 
(Kuo and Tuan 2003; Merceron et al. 2010).  Induction of the desired phenotype is 
generally accomplished through chemical induction, but may also be accomplished 
through manipulation of the cellular microenvironment by manipulating the attachment 
substrate or external forces.  No matter the method or combination of methods chosen, a 
robust and repeatable induction protocol is necessary to achieve the desired phenotype and 
to avoid the development of non-desirable tissue traits. 
2.3.1.2 Scaffolding 
Tissue-engineering approaches typically employ exogenous scaffolds intended to 
recapitulate the three-dimensional extracellular matrix and provide mechanical support 
during the early stage growth of the engineered construct (Kim and Mooney 1998).  
Typically, a well-designed scaffold with be highly porous with an interconnected pore 
network to accommodate the transport of nutrients and wastes from the seeded cell 
population to allow for cell proliferation and elaboration of a tissue specific matrix.  
Additionally, the material should have material properties such that it is biocompatible, 
bioresorbable, and of appropriate stiffness to meet the functional requirements of the target 
tissue either on its own or in concert with the properties of accumulated neotissue following 
cultivation.  Given that the scaffold must be both bioresorbable and mechanically function 
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will require careful matching of the dynamics of scaffold degradation and neotissue 
accumulation such that the accumulated matrix can fill both the physical space vacated by 
the scaffold and its role in supporting further development in vitro or intended function in 
vivo.  In attempts to meet these criteria, a myriad of natural and synthetic polymers have 
been investigated as potential scaffolding materials for cartilage and osteochondral tissue 
engineering applications.  Structurally, the materials generally take on one of several 
forms:  woven or non-woven meshes, ordered or random open cell structures, and 
hydrogels (Dietmar W 2000).  Among these forms, hydrogels are of particular interest due 
to their diffusion properties, wide availability, and capability to be homogeneously seeded 
by mixing a concentrated cell solution with the polymer solution prior to gelation (Vinatier 
et al. 2006).  Further, hydrogels are highly customizable in terms of gelling mechanisms 
for manufacturing and incorporation of biomimetic features to permit cellular processes 
such as adhesion, migration, proliferation, and differentiation.   
2.3.1.3 Bioreactors 
Bioreactors are systems which allow for biological processes to develop under tightly 
controlled environmental and operating conditions (e.g. pH, temperature, pressure, nutrient 
supply and waste removal) (Martin et al.). Within the context of tissue engineering and in 
vitro tissue culture, bioreactors permit the cultivation of larger, better organized engineered 
cartilage than can be grown in static Petri dishes (Concaro et al. 2009; Darling and 
Athanasiou 2003; Haasper et al. 2008).  This is due in large part to the flow and mixing of 
culture media within bioreactors that is expected to affect tissue formation in at least two 
ways: by enhancing mass transfer and by direct physical stimulation of the cells (Bilgen et 
al. 2005; Bilgen et al. 2006; Boschetti et al. 2005; Cinbiz et al. 2010; Hutmacher and Singh 
2008; Kenneth A. Williams 2002; Lawrence et al. 2009; Sucosky et al. 2004; Yao and Gu 
2004b).  Depending on the application, several configurations of bioreactors have been 
well studied in the literature for the purpose of cartilage and/or osteochondral tissue 
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engineering (Figure 2.5).  In vivo, mass transfer to chondrocytes involves diffusion and 
convective transport by the fluid flow that accompanies tissue loading (Albro et al. 2008; 
Mow et al. 1984). In vitro, the bioreactors achieved convective mass transport either 
through compressive loading intended to mimic physiological loading, direct perfusion of 
the tissue construct through the action of an external pump, or through mixing of the culture 
media around the constructs to enhance mass transport at construct surfaces.  As the 
development of the tissue construct occurs over time, transport provided to the construct 
surface may become insufficient for the cells embedded deep within large tissue constructs 
resulting in nutrient transport becoming the key limiting factor the functionality of tissue 
derived from the cultivation process. 
 
Figure 2.5:  Bioreactor Configurations for Tissue Engineering 
Bioreactor systems in cartilage tissue engineering. (A) Confined and unconfined 
compressive loading. (B) Shear deformation. (C) Hydrostatic pressure. (D) Direct 
perfusion. (E) Rotating vessel. (F) Spinner flask.  Image adapted from Yang, Y.-H. and 
Barabino, G.A. (in press) Environmental Factors in Cartilage Tissue Engineering. Tissue 
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and Organ Regeneration: Advances in Micro and Nanotechnology. Editors: Zhang, L.G., 
Khademhosseini, A. and Webster T. 
 
Although the tissue-engineering strategy is not widely implemented clinically, it presents 
obvious advantages when compared with traditional treatments. First, the tissue 
engineering paradigm in which autologous cells are utilized in the production of the 
construct ensures immunocompatibility and eliminates the disease transmission worries of 
traditional allografts. Second, bioreactor technologies allow for the optimization of the 
cultivation process to ensure the repair tissue is mechanically and physiologically 
functional.  Finally, the scale-up made possible through the culture of such bioartificial 
substitutes solves the problem of the critical donor shortage presently limiting the 
application of the transplantation technique. Those benefits justify the current efforts to 
better control this treatment strategy and to address its challenges. 
 Osteochondral Tissue Engineering 
Having covered the general philosophy of tissue engineering, it is also pertinent to review 
the literature on common approaches specific to repairing articular cartilage and the 
osteochondral unit.  Challenges specific to this biphasic tissue include spatially varying 
material properties, cell types, and biochemical composition and the development of 
appropriate bioreactors and bioprocessing procedures for the cultivation of osteochondral 
grafts.  Regarding cell sourcing and scaffolding selection, the literature can be grouped into 
three primary categories:  primary chondrocytes alone (Hung et al. 2003; Kandel et al. 
2006; Kreklau et al. 1999; Niederauer et al. 2000; Waldman et al. 2003a; Wang et al. 2004), 
spatially segregated chondrogenic and osteogenic sources (Cao et al. 2003; Schaefer et al. 
2002; Schaefer et al. 2000; Schek et al. 2004), and a multipotent stem cell source having 
both chondrogenic and osteogenic differentiation capacity (Alhadlaq et al. 2004; Gao et al. 
2001a; Tuli et al. 2004).  Additionally, acellular regenerative approaches employing only 
a scaffold or a scaffold loaded with cellular recruitment factors have been pursued (Fukuda 
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et al. 2005).  Of the cell-based approaches, the stem cell strategy suffers from the least 
tradeoffs in terms of proliferative capacity and sourcing material scarcity.  These cell 
groups have then be seeded onto a number of scaffolding materials and architectures 
including:  (I) scaffold-free approach for the chondrogenic region coupled with a 
scaffolded approach for the bony region, (II) separate scaffolding strategies for each region, 
and (III) a single scaffolding strategy for both regions (Martin et al. 2007).  For instance, 
Tuli et al. utilized strategy (I) by coating polylactic acid (PLA) scaffolds with progenitor 
cells of mesenchymal origin to produce osteochondral grafts.  One face of the grafts was 
seeded with cells precultured in chondrogenic media, while the other was coated with cells 
precultured in osteogenic media.  Following seeding the constructs were cultured in a 
mixed-cocktail media with the goal of promoting chondrogenesis and osteogenesis 
simultaneously (Tuli et al. 2004).  Following culture, construct exhibited hyaline cartilage 
overlying a bony region with an interface between the two regions resembling the tidemark 
of the native tissue.  While the results of this study were promising, the approach was non-
optimal as it required redundant cultures prior to scaffold incorporation and subjected to 
the construct to non-optimal maintenance media rather than media which might further 
promote region specific properties.  As for the second scaffolding strategy, Gao et al. 
reported osteochondral constructs by combining precommitted MSCs into a hyaluronate-
ceramic composite scaffolds (Gao et al. 2001b).  Like the study by Tuli et al., these 
constructs also required a predifferentiation step prior to incorporation into the composite 
scaffolding.  They also required the use of a glue to incorporate the two layers together.  
When implanted subcutaneously in an immunocompromised mouse model for six weeks 
the constructs showed evidence of non-desirable collagen type I expression within the 
chondral region for a more fibrocartilaginous character than that of the desired hyaline 
composition.  Significant results using the third strategy in which a single, homogenous 
scaffold seeded with a common cell source include the work of Alhadlaq et al in which 
they separately predifferentiated progenitor cells of mesenchymal origin and incorporated 
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them into two integrated PEG hydrogel layers through sequential photopolymerization 
(Alhadlaq et al. 2004).  This approach resulted in spatially separated synthesis of 
cartilaginous and bony matrices following 4 weeks of implantation into a mouse model.  
The common limitation present in each of the highlighted studies above is the reliance on 
a predifferentiation step prior to incorporating the mesenchymal progenitor cells into the 
osteochondral scaffold.  This reliance on predifferentiation limits the usefulness of these 
approaches test beds for studying the development of tissues and makes them commercially 
less viable as they require longer times in culture, which increases their production cost 
relative to a solution in which the cells can be differentiated in situ with spatial specificity.  
Advancement of the production of tissue engineered medical products for osteochondral 
repair will require further development of enabling technologies to better control the 
culture of the cell source for both differentiation and promotion of region specific matrix 
development. 
 
 Microfluidic Scaffolding in Tissue Engineering 
Microfluidic systems have gained popularity as a way to mitigate the issues of cultivating 
large, densely populated constructs, by combining the three pillars of the tissue engineering 
triad into a single highly controllable complex.  The incorporation of microchannels 
throughout the construct allows for convective transport of nutrient and oxygen into and 
waste products out of the developing tissue creating the potential for the creation of 
function tissues and the ability to control spatiotemporal presentation of nutrients, 
cytokines, growth factors, and other morphogens (Huang et al. 2011).  Hydrogels are an 
optimal target material class for the embedding of microfluidic channels due their 
advantageous diffusion properties, tunable mechanical properties, and ease of production.  
Additionally, the presence of arranged channels reduces the resistance to perfusion of 
hydrogel constructs effectively increasing the perfusion capacity.  By incorporating 
multiple independent networks within a single construct, microfluidics also offers the 
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ability to impart spatial complexity on the tissue as networks can be differentially loaded.  
To date several groups have attempted to utilize the concept of microfluidic hydrogels for 
cell and tissue culture (Bettinger and Borenstein 2010; Borenstein et al. 2010; Golden and 
Tien 2007; Johann and Renaud 2007; Ling et al. 2007; Song et al. 2009), a primary focus 
on fabrication techniques and characterization of transport properties (Figure 2.6).   
 
Figure 2.6:  Overview of Pioneering Microfluidic Hydrogel Technologies 
The pioneering work in the field of microfluidic hydrogels focused on fabrication 
technologies, characterization of transport properties and assessment of cell viability. 
 
The first significant reports of microfluidic hydrogels appeared in 2007 when Ling et al., 
Golden et al. and Choi et al. separately reported transport characteristics and cell viability 
measurement in agarose, collagen, and calcium-alginate based hydrogels respectively.  
Choi et al. provide a particularly nice treatment of the mass transport properties by both 
transient measurement of FITC-labeled BSA and diffusion-reaction dynamics of a live 
dead stain using two independent networks spatially separated within the same plane.  
While Ling et al. and Choi et al. used molding techniques to produce their microfluidic 
networks, Golden et al. utilized a sacrificial element approach to selectively degrade the 
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microchannel space (Golden and Tien 2007).  Subsequent studies, expanded on these 
works to include further optimization of transport and assessment of mechanical properties.  
For instance, Park et al (2010) fabricated a micro-porous cell-laden agarose hydrogel with 
a single microfluidic channel formed via insert molding around a capillary tube (Park et al. 
2010).  Additionally the porosity of the agarose was modulate via the introduction of 
sucrose crystal.  Utilizing this system, hepatocytes were cultured for a period of 5 days.  
Mass Transport properties of the microfluidic hydrogel were assess via a FITC-labeled 
tracer and viability assessed via a live-dead stain and image analysis.  Primary findings 
indicated that transport properties and hepatocyte viability were increased with sucrose 
incorporation while mechanical properties were decreased.  In summary, these studies have 
modeled nutrient transport using one and two dimensional diffusion-uptake models (Song 
et al. 2009), exhibited cell viability of short culture periods (Bettinger and Borenstein 2010; 
Borenstein et al. 2010; Golden and Tien 2007; Ling et al. 2007; Song et al. 2009), or only 
studied a single channel system (Ling et al. 2007),  but none have extended their analysis 
to three dimensional studies of nutrient transport or extended culture periods, a critical step 






3 DEVELOPMENT AND VALIDATION OF A MICROFLUIDIC 
HYDROGEL FOR TISSUE ENGINEERING† 
†Portions of this chapter are adapted and modified from: Stephen M. Goldman and Gilda 
A. Barabino.  Long-Term Culture of Agarose-Based Microfluidic Hydrogel Promotes 
Proliferation and Development of Critically Sized Tissue Engineered Articular Cartilage 
Constructs, Journal of Tissue Engineering & Regenerative Medicine, Available Online 4 
SEPT 2014, DOI:10.1002/term.1954. 
 Introduction 
Tissue-engineered cartilage constructs show great promise as a future regenerative therapy 
for patients suffering from PTOA by offering the potential to relieve symptoms and prolong 
patient mobility without the inherent disadvantages of total joint arthroplasty.  Even so, 
challenges persist and clinically relevant successes have proven difficult to achieve.  Chief 
among these challenges is poor mass transfer and nutrient transport to the interior of large, 
full-thickness constructs resulting in large gradients in cell viability and matrix deposition 
as well as inadequate mechanical functionality (Bueno et al. 2008; Bursac et al. 1996).  
Various approaches have been taken to improve the influx of nutrients and efflux of wastes 
from the bulk of hydrogel constructs including altering the density and geometry of the 
inherent pore structure of hydrogel scaffolding (Annabi et al. 2010; Hollister et al. 2002; 
Hwang et al. 2010) and forced convection approaches in which media is perfused through 
the construct (Davisson et al. 2002; Porter et al. 2005).  The effects of the former of these 
approaches are short lived as cell proliferation and matrix deposition quickly fill the void 
space in the nanoporous hydrogels, and the latter approach requires large pressure heads 
due to the low permeability of the constructs.  Embedded microfluidic channels offer the 
potential to maximize the perfusion capacity, create spatial complexity, and allow control 
over the spatial and temporal presentation of hydrodynamic and chemical cues within the 
developing construct (Bettinger and Borenstein 2010; Bettinger et al. 2005; Borenstein et 
al. 2010; Choi et al. 2007b; Golden and Tien 2007; Huang et al. 2011; Johann and Renaud 
2007; Khademhosseini et al. 2006; Ling et al. 2007; Song et al. 2009; Sugiura et al. 2011).  
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Methods for the production of the microfluidic channels include molding (Borenstein et al. 
2010; Choi et al. 2007a; Ling et al. 2007), bioprinting (Boland et al. 2007; Lee et al. 2010), 
photopatterning (Cuchiara et al. 2010; Lee et al. 2008), and use of sacrificial elements 
(Golden and Tien 2007).  These pioneering studies, however, have fallen short of achieving 
a microfluidic construct which is sufficiently thick and robust for long term culture of tissue 
engineered substitutes.   
 
We designed and characterized a microfluidic agarose-based construct for articular 
cartilage replacements by first determining the parameters for an optimal microfluidic 
network in terms of the number, size and spacing of channels, as well the material 
properties of the agarose hydrogel, the rate of perfusion of media through channels, and 
the cell seeding density, factors known to impact the distribution and utilization of 
nutrients, wastes, and chemical signaling molecules in tissues (Devarapalli et al. 2009; 
Galban and Locke 1999; Huang et al. 2011; Roberts et al. 2011; Sengers et al. 2005; Song 
et al. 2009; Yao and Gu 2004a). Chondrocyte-seeded, agarose-based microfluidic 
constructs were cultivated for up to two weeks and evaluated for cell proliferation and 
elaboration of a cartilaginous matrix relative to solid, statically cultured controls.  
Specifically, we are interested in the production of Collagen II and glycosaminoglycans 
within the construct as these are the primary components of the cartilaginous matrix which 
contribute to the unique biomechanical properties of the tissue (Mow et al. 1980). 
 Microfluidic Construct Design 
In designing our microfluidic construct, we assumed a spatially homogeneous population 
of bovine articular chondrocytes encapsulated within an agarose gel, and embedded with a 
microfluidic network of square cross section (Figure 3.1).  An additional requirement was 
that, microfluidic channels within tissue constructs be distributed such that the 
encapsulated cells are all well-nourished.  Therefore, the design parameters for the 
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construct include the nominal dimensions of the construct, microchannel spacing, and 
number of microchannels, volumetric flow rate, cell seeding density, and the solid volume 
fraction of the agarose gel.   
 
Figure 3.1:  Microfluidic Construct Geometry  
(A) Cross-section of microfluidic construct. (B) Approximation of construct as a tissue 
cylinder. The effective length of the cylinder is the total length of the microfluidic network, 
including bends, with construct with design equations defining the relationship between 
the nominal dimensions of the construct to the number and spacing of the microchannels. 
(C) A volume of interest was defined within the perfusion-cultured microfluidic constructs, 
on which all data analysis was performed to avoid edge effects and achieve geometric 
similarity with the static controls 
 
To simplify the design process, the construct was modeled as a single cylindrical unit with 
an effective length (Leff) equal to the total length of the serpentine microfluidic network as 
defined in Equation 3.1, where 𝑁𝑏𝑒𝑛𝑑 and 𝑁𝑐ℎ𝑎𝑛𝑛𝑒𝑙 are the number of 180° bends and 
network passes respectively.  𝐿𝑏𝑒𝑛𝑑 and 𝐿𝑐ℎ𝑎𝑛𝑛𝑒𝑙 are the equivalent length of the bend and 
each network pass respectively defined in terms of the construct dimensions and channel 
spacing. 
 Leff = NbendLbend + NchannelLchannel (3.1) 
Appropriate spacing for the microchannels was determined based on a two-dimensional 
axisymmetric diffusion-consumption analysis.  For the system under consideration, the 
Thiele modulus (φ) can be expressed in terms of the inner (𝑅𝑖) and outer (𝑅𝑂) radii of a 
single cylindrical tissue unit (Equation 3.2), with appropriate diffusion and kinetic 












Table 1.1:  Parameters for Microfluidic Construct Design  













µmedia 1.00 cP 
Qmedia 0.25 cm
3/min 
#as reported by Sengers et. al. 2005 
$Calculated using Mackie-Mears Relationship 
 
The outer radius of this unit represents the extent to which encapsulated cells are well 
nourished.  With an inner radius corresponding to the fixed hydraulic radius, and an upper 
bound set on the Thiele modulus of 0.3 to ensure no mass transfer limitations on glucose 
consumption, the maximum metabolically allowable spacing (on center) between two 
adjacent cylindrical units, λ, can be expressed as twice the maximal outer radius (Equation 
3.3). 
λ = 2𝑅𝑜 (3.3) 
The final design parameter for the construct is the volumetric flow rate of the culture media 
through the microfluidic network.  The calculation determining the maximal channel 
spacing distance is dependent on the fact that the concentration at the microchannel walls 
is at quasi steady state.  To ensure nutrients in the channel are not appreciably diminished, 
it is necessary to set the flow rate at the inlet sufficiently high to provide nutrients at a rate 
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greater than the rate of consumption.  If a constraint requiring the outlet concentration (Cout) 
be within 1% of the inlet concentration (C0) is placed on the system (Equation 3-4), the 
required volumetric flow rate (Q) through the construct can be stated in terms of the 
construct dimensions, cell seeding density (𝜌𝑐𝑒𝑙𝑙), kinetic parameters, and nutrient 
concentrations (Equation 3-5). 
Cout = 0.99C0 (3.4) 






These equations (3.1-3.5) when solved simultaneously for varying cell seeding density and 
hydrogel properties provide design parameters for the production of microfluidic articular 
cartilage constructs. 
 Parametric Study of Bioprocessing Parameters 
A parametric analysis was performed to determine the maximal channel spacing and 
minimal flow rate criteria for transport of glucose within a construct of arbitrary 
dimensions.  Construct dimensions were constrained to a footprint of 17.5mm x 17.5mm 
while the microfluidic network was defined to have a 425 µm square section to 
accommodate traditional machining. Cell seeding density and agarose concentration were 
varied across the ranges established from the literature to provide the following flow rate 





Figure 3.2:  Bioprocessing Guidelines for Microfluidic Tissue Construct 
Bioprocessing guidelines for the production of tissue-engineered articular cartilage, using 
the geometric constraints described herein.  Maximum microchannel spacing (A) and 
minimum volumetric flow rate (B) are were found through parametric analysis and plotted 
as contours to provide bounding conditions for varying cell-seeding densities and hydrogel 
properties. The effective diffusivity (x axis) is plotted in lieu of agarose weight percentage 
for extension of the analysis into alternative material systems. Effective diffusivity is 
related to the weight percentage of agarose in the cell–prepolymer solution by the Mackie–
Mears relationship. Values represent bounding conditions for the cell-seeding densities and 
hydrogel properties commonly observed in the cartilage tissue-engineering literature 
 
The smallest maximum channel spacing for the range of conditions studied herein was 557 
µm occurring at a seeding density of 100 million cells per milliliter and a 5% agarose 
solution.  The greatest channel spacing recommendation was 820 µm occurring at a seeding 
density of 10 million cells per milliliter and a 1% agarose solution.  Recommended minimal 
flow rates ranged from 55.95 to 248.50 µL/min at the low and high end of range of 
independent parameters respectively.  At these flow rates the magnitude of shear stress on 
the microchannel walls would range from 5.39x10-3 dynes/cm2 to  0.239 dynes/cm2 




3  (3-6) 
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These values are well within the estimated range of shear stresses due to interstitial fluid 
flow in articular cartilage in vivo.  This is an important realization as it will allow this 
microfluidic hydrogel approach for future mechanobiological studies in which the wall 
shear stress is varied without significant impact on nutrient transport for a range of cell 
seeding densities and hydrogel material compositions. 
 Materials & Methods 
3.4.1 Chondrocyte Isolation 
Bovine articular cartilage explants were prepared from the femoral condyles and patellar 
groove of 2–4 week old calves (Research 87, Marlborough, MA) and finely minced into 
pieces with a characteristic length of less than 1mm.  The explants were then digested in a 
type II collagenase solution (90% DMEM, 10% FBS and 4-5 U of enzyme/mL) and 
incubated (37°C, 5% CO2) under agitation for 48 hours.  Following digestion, the solution 
was filtered through a 40 µm mesh to remove undigested tissue and assessed for cell 
number and viability using an automated cell counter (Nexcelom Biosciences, Lawrence, 
MA) and trypan blue exclusion assay.  The chondrocytes were then isolated from the 
resulting solution by centrifugation and suspended in a cryoprotective medium (70% 
DMEM, 20% FBS, 10% DMSO) at a concentration of 1 million cells/mL and stored in 
liquid nitrogen in 1mL aliquots. 
3.4.2 Construct Fabrication 
The selected construct design was that of a serpentine network with 425µm x 425μm square 
cross-section spaced 850µm apart on center within the recommended specifications 
provided by the solution of Equations 3.1-3.5 such that the acrylic casings and negative 
reliefs of the microfluidic network could be produced through micromachining (HAAS 
Automation, Inc., Oxnard, CA).  Construct molds were produced by pouring 
Polydimethylsiloxane (PDMS) into the acrylic molds and curing the polymer at 90°C for 
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90 minutes following degassing under vacuum.  Molds were then exposed to oxygen 
plasma for 30 seconds to render the surface of the molds hydrophilic, and subsequently 
steam sterilized.  Primary chondrocyte aliquots from three animals were thawed, pooled, 
and mixed into a 2.5% agarose gel at a density of 25 million cells/mL.  Microfluidic 
constructs were then produced by casting the cell-agarose solution between the acrylic 
casing and the PDMS mold, and allowing to gel at room temperature for 20 minutes.  The 
molded portion was then sealed against a planar slab of the cell-agarose solution to 
complete the construct as depicted in Figure 3.3.  Control constructs were produced by 




Figure 3.3:  Fabrication Process for Microfluidic Constructs 
The microfluidic construct fabrication is depicted in (A) from left to right. First, the PDMS 
mold of the microfluidic network is sandwiched between two machined acrylic casings, 
detailed in (B), and held together with bolts. Then, the cell–prepolymer solution is injected 
through the loading ports via a syringe and allowed to gel for 15 min. The PDMS mold, 
detailed in (C), is then removed and replaced by a planar slab of cell-laden agarose from 
the same prepolymer batch as the molded portion of the construct, detailed in (D). The two 
construct portions are secured between the two acrylic casings, and external plumbing is 
connected for culture medium perfusion. 
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3.4.3 Tissue Culture 
External plumbing was connected through the acrylic casing and culture commenced under 
constant perfusion at a volumetric flow rate of 250 μL/min.  The prescribed flow rate was 
selected to both fulfill the minimal flow rate requirements for the chosen design as shown 
in Figure 2, and to provide a uniform shear stress distribution of 1 dyne/cm2 at the 
microchannel walls in the central region of interest.  Constructs were connected to 
independent flow loops through which media was recirculated via a syringe pump equipped 
with dual check valves to achieve unidirectional flow.  A gas exchange reservoir was 
connected to the flow loop and a 5% CO2 mixture bubbled through the culture media to 
maintain pH.  Total culture media volume was maintained at 100mL and fresh media 
exchanges were performed every 3-4 days through sampling ports attached to the gas 
exchange reservoir.  Control constructs were cultured in 6-well plates supplied with 5mL 
of fresh media every 3-4 days. 
3.4.4 Defining a Volume of Interest 
As an initial proof of concept for the prototype system, tissue culture experiments were 
carried out to monitor the development of cartilaginous neotissue over the course of a 2-
week cultivation period and developing constructs were evaluated relative to static free 
swelling controls.  To achieve geometric similarity across experimental groups and avoid 
adverse concentration gradients due to edge effects, a volume of interest (VOI) was defined 
for analysis of the perfused microfluidic constructs.  The VOI is a cylindrical region (d= 
10mm, h= 2.5mm or 5.0mm) centered within the construct volume as depicted in Figure 1.  
Biochemical, mechanical, and histological analyses were performed on the VOI only.   
3.4.5 Biochemical Analyses 
Prior to biochemical analyses, constructs were weighed (wet weight), frozen, lyophilized, 
weighed (dry weight), and digested with papain enzyme  in 0.1 M sodium acetate 
containing 0.05 M ethylenediaminetetraacetic acid and 0.01 M cysteine-HCl for 16 hours 
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at 60°C. Construct cell content was assessed from the DNA content of construct digests 
using a PicoGreen double stranded DNA kit. The construct glycosaminoglycan (GAG) 
content was assessed spectrophotometrically at 525 nm using a 1, 9-dimethylmethylene 
blue dye-binding assay (Farndale et al. 1982).  The concentration of hydroxyproline was 
measured spectrophotometrically at 550 nm after acid hydrolysis and reaction with 
chloramine-T and 4-Dimethylaminobenzaldehyde. The total collagen content was 
calculated assuming a 1:10 hydroxyproline to collagen concentration ratio.  
3.4.6 Mechanical Analyses 
An unconfined compression testing protocol was used to measure the dynamic modulus of 
the constructs on an ELF3200 testing frame (Enduratec, Minnetonka, MN). The constructs 
were placed in the chamber and preloaded to 0.01 N to establish contact with the sample. 
For dynamic modulus, 5% peak-to-peak sinusoidal strains at frequencies in the range of 
0.01-10 Hz were applied at a static offset strain of 10%. The dynamic modulus was 
calculated, at a frequency of 1 Hz, as the ratio of the measured oscillatory load normalized 
by the circular area of the disc to the amplitude of the applied displacement normalized by 
the thickness of the construct. 
3.4.7 Histology & Immunofluorescence 
For histological analysis, constructs were fixed in 10% buffered formalin, embedded in 
paraffin and sectioned into 5μm thick sections for the midsubstance of the construct.  
Sectioned samples were stained with safranin-O solution according to the manufacturers’ 
instructions. For immunofluorescence, sections were incubated with a citrate buffer heated 
to 99°C for 30 min to retrieve antigens, and allowed to cool to room temperature. The 
samples were then incubated in blocking buffer for 30 minutes and primary rabbit anti-
bovine Collagen II antibodies (1:100, Abcam, Cambridge, MA) at 4°C overnight. Sections 
were then washed three times in PBS and with DyLight®594 goat anti-rabbit secondary 
antibodies (1:200, Abcam, Cambridge, MA) for one hour at room temperature.  Finally, 
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samples were washed and mounted with Vectashield with DAPI  and visualized on a Nikon 
Ti Eclipse inverted fluorescence microscope (Nikon Instruments, Inc., Melville, NY), with 
representative images captured using a CoolSNAP HQ2 CCD camera (Photometrics, 
Tucson, AZ).  
3.4.8 Statistical Analyses 
Independent experiments produced construct samples for mechanical analyses (N=3 per 
group), histology (N=3), and biochemical analyses (N=12 for 2.5mm samples, N=3 for 
5mm samples).  For all image analysis of histology specimens, the minimum number of 
images required to accurately represent the whole section were used. Data for mechanical 
testing and biochemical analysis is reported as the mean ± SEM with statistically 
significant differences defined as p < 0.05 using two-way ANOVA with Bonferroni post-
hoc tests for multiple comparisons. 
 Results 
3.5.1 Biochemical Composition 
DNA content increased with cultivation time for both solid, static cultures and microfluidic 
constructs.  This effect was significantly greater in the perfused microfluidic construct 






Figure 3.4:  Biochemical Composition of Microfluidic Constructs 
Biochemical composition of statically cultured solid constructs and perfused microfluidics 
constructs expressed as a mass fraction. Samples sizes for assays were n=12 for 2.5mm 
samples, n=3 for 5mm samples: &, && statistically significant (p<0.05) differences with 
respect to the 2.5 and 5mm control construct groups, respectively, at the 1week time point; 
^, ^^ statistically significant (p<0.05) differences with respect to the 2.5 and 5mm control 
constructs groups, respectively, at the 2week time point; #, ##statistically significant 
(p<0.05) differences with respect to the 2.5 and 5mm microfluidic construct groups, 
respectively, at the 1 week time point; *, ** statistically significant (p<0.05) differences 
with respect to the 2.5 and 5mm microfluidic constructs groups, respectively, at the 2week 
time point 
 
Additionally, collagen accumulated in each experimental group over time with the 
exception of the 2.5mm thick statically cultured constructs.  When the construct thickness 
is increased to 5mm, collagen synthesis in the microfluidic geometry is significantly 
increased relative to both the statically cultured construct and the thinner microfluidic 
constructs at both time points.  GAG content within each group increased significantly 
within the first week of culture and remained statistically unchanged thereafter for all 
groups with the exception of the 5.0mm thick control group, which increased significantly 
during the second week of culture rather than the first.  There was no statistical difference 
in GAG concentration between any of the groups at the two week time point. 
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3.5.2 Mechanical Properties 
The dynamic modulus of the constructs across all conditions ranged between 159.8 kPa for 
the 2.5mm thick, statically cultured control and 328.8 kPa for the 2.5mm thick microfluidic 
construct.  There was no statistical difference in modulus for the different culture 
conditions for a given culture period.  There was a significant difference in moduli for each 
culture condition at 2 weeks relative to the acellular control and the identical culture 
condition at the 1 week time point for the 2.5mm thick constructs (Figure 3.5).   
 
 
Figure 3.5:  Mechanical Properties of Microfluidic Constructs 
Storage modulus and phase delay for constructs of solid and microfluidic architectures for 




Within the 5mm construct grouping, the statically cultured construct exhibited a significant 
increase in dynamic modulus versus the acellular control at the 2 week time point.  The 
phase delay of the constructs varied between 8.57° for the 2.5mm microfluidic construct at 
1 week and 14.46° for the 5mm static construct at 1 week.  None of the conditions, 
however, produced differences which are considered statistically or practically significant.   
3.5.3 Histological & Immunofluorescence Staining 
Control constructs stained weakly and relatively homogeneously for both GAG and 
Collagen II for all culture periods (Figure 3.6).  At the one week time point there was no 
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noticeable difference in Collagen II or GAG staining between the microfluidic and control 
constructs.  At the two week time point, however, there is increased GAG staining in the 
construct space between microchannels.  The staining is not homogeneous, but rather 
confined to the microenvironment immediately surrounding the chondrocytes. 
 
Figure 3.6:  Histological Staining of Microfluidic Cartilage Constructs 
Staining of Collagen II (top) by immunohistochemistry and GAGs (bottom) by safranin O. 
The stains suggest that the microfluidic channels provide local increases in both 
extracellular matrix components at both time points. For immunofluorescence, green and 
blue pseudo-colorings are applied for Collagen II and nuclei, respectively; the images are 




The purpose of this study was to investigate the incorporation of microfluidic networks in 
cell-laden agarose gels as an approach to improve cell proliferation and biosynthesis in 
tissue engineered constructs of clinically relevant thicknesses.  As evidenced by an increase 
in DNA and collagen contents with time for 2.5 mm and 5 mm thick microfluidic constructs 
cultivated for 2 weeks, over that for corresponding solid control constructs, our design 
achieved a measure of success.   
 
Others have demonstrated the feasibility of directly perfused microfluidic channels within 
hydrogels, yet in these studies culture periods were short (up to three days) and constructs 
were limited to thicknesses less than 2mm (Choi et al. 2007a; Golden and Tien 2007; 
Johann and Renaud 2007; Ling et al. 2007).  Buckley et al were able to produce a large 
microchanneled tissue construct which they cultivated under rotational culture (Buckley et 
al. 2009).  The key difference between rotational and direct perfusion culture lies in the 
ability to control mass flow and shear rates to the construct interior rather than relying on 
convection from the external flow in rotational culture.  One anticipated benefit of our 
construct design relative to other directly perfused microfluidic constructs was that a 
slightly larger microchannel cross-section would accommodate greater neotissue 
accumulation within the construct without resulting in flow occlusions do to tissue in 
growth into the microchannels over time.  By extending the culture duration to two weeks, 
we were able to parse the role of fluid shear within the construct in regulating the synthesis 
of collagen by the embedded chondrocytes.  The increased collagen synthesis in the thick 
constructs relative to the thin constructs suggests that this effect may be impacted by the 
increased internal surface area over which shear stress is applied due to the presence of the 
second microfluidic network.  The presence of a second fluidic network within the thicker 
construct doubled the amount of surface area exposed to shear, an effect that was 
recapitulated in the construct collagen composition at one and two-week time points.  The 
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lower nominal values of cartilage specific matrix molecules within the microfluidic 
constructs may be due to shear stimulated release of secreted macromolecules into the 
culture media (Grad et al. 2012).  We expect that even longer culture periods are possible 
using our approach, as even after two weeks in culture, flow within microfluidic channels 
did not become occluded. 
   
Additionally, we were able to increase the thickness of the microfluidic construct to 5mm, 
approaching the maximum thickness of the femoral condyle (Ateshian et al. 1991), by 
incorporating an independent, supplemental microfluidic network offset from the original 
network.  While prior studies alluded to the concept of incorporation multiple networks for 
building construct thickness (Choi et al. 2007a; Cuchiara et al. 2010; Golden and Tien 
2007; Huang et al. 2011; Johann and Renaud 2007; Ling et al. 2007; Song et al. 2009), our 
study extends the concept by establishing the feasibility of culturing such constructs for 
extended periods, and showing that this strategy results in greater cell viability relative to 
solid, statically cultured constructs of the same thickness. 
   
One limitation of our design is that multiple fluidic networks may negatively impact the 
apparent mechanical properties of the tissue engineered construct.  As expected, the 
modulus of the constructs increased with time concurrently with the increase in 
extracellular matrix components.  However, no significant difference between the solid and 
microchanneled architectures was observed for the thinner geometry, and the incorporation 
of a second fluidic network resulted in a decrease in apparent properties. For successful 
clinical implementation, the use of multiple fluidic networks will require manipulation of 
additional factors such as an alternative material platform, and further investigation into 
the mechanics of a microchanneled construct.  There was no statistical difference in the 
phase delay of the constructs under dynamic compression.  Since the phase delay indicates 
a measure of the viscoelasticity of the constructs, this finding indicates that the magnitude 
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of any changes in the viscoelasticity of the constructs due to neotissue development are 
dominated by the viscoelastic properties of the agarose scaffolding for the culture periods 
studied. 
 
We selected an agarose hydrogel as the material for our microfluidic constructs based on 
its demonstrated suitability for cultivation of chondrocytes. For these agarose-based 
microfluidic hydrogels, we found that the incorporation of the microfluidic network and 
application of shear stress due to culture media perfusion affected cell proliferation and 
matrix elaboration in a similar manner to other forms of mechanical environment 
perturbations including dynamic compressive and shear loading.  The effects of dynamic 
loading, under compression and shear, have been repeatedly shown to increase 
cartilaginous matrix synthesis, chondrocyte proliferation, and construct modulus over a 
range of stimulation frequencies and culture durations (Buschmann et al. 1995; Mauck et 
al. 2000; Waldman et al. 2003b; Waldman et al. 2004).  Our results are in agreement with 
previous reports of increased cell proliferation and collagen production, but contrast 
findings with respect to GAG production, as the beneficial effect of loading on GAG was 
not observed in our microfluidic constructs.  We speculate that the presence of the 
microfluidic network(s) may have contributed to the loss of newly synthesized GAG to the 
culture medium due to the relatively high velocities within the microfluidic channels, a 
mechanism not present in dynamic loading studies, thus even if GAG production was 
stimulated in response to mechanical stimuli, losses to the media could prevent detection 
of an increase.   
 
We expected that incorporating microfluidic channels and increasing construct thickness 
would confer improved mechanical properties, however, improvements were not observed, 
particularly for the thicker construct in which two fluidic networks were incorporated.  In 
the case of the 5mm microfluidic construct, a likely explanation for the decrease in apparent 
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mechanical properties is reduced construct mass due to the increased void space necessary 
to incorporate the microfluidic network. Given that mechanical stimulation tends to have a 
greater effect when more ex novo matrix is present (Bueno et al. 2008; Buschmann et al. 
1995; Mauck et al. 2000), we predict future, longer term studies in our microfluidic system 
may prove even more effective than static controls. 
 Conclusions 
We have developed a microfluidic culture system designed to meet nutrient transport 
requirements of a large, full-thickness articular cartilage construct over a two week culture 
period, and shown that the incorporation of the microfluidic network and perfusion of 
culture media through the network resulted in significant enhancement of cell proliferation 
and increases in dry weight fractions of both GAG and collagen for 5mm thick constructs. 
Incorporation of multiple fluidic networks within the agarose construct resulted in a 
decrease in the apparent dynamic modulus of the construct.  Our findings that approaching 
thicker and more robust constructs through incorporation of microfluidics in agarose-based 
hydrogels led to improvements in proliferation and matrix deposition to some extent, but 
not apparent mechanical properties suggests that for this platform to have clinical utility, 
future studies involving longer cultivation periods, alternative material selection, and 
further optimized bioprocessing parameters are needed. 
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4 EFFECT OF HYDRODYNAMIC LOADING ON 
MESENCHYMAL STEM CELL DIFFERENTIATION 
EFFICIENCY 
 Introduction 
Due to their limited supply and decreased proliferative capacity, the sole use of autologous 
chondrocytes and osteoblasts for regenerative medicines is likely unsustainable (Mauck et 
al. 2006).  Subsequently, mesenchymal stem cells (MSCs) have emerged as a clinically 
relevant cell source for regenerative medicine, due to their ease of procurement, 
multipotentiality, high proliferation rate, and ability to be expanded in vitro while 
maintaining a stable phenotype (Bruder et al. 1997; Caplan 2005; Pittenger et al. 1999).  
Directed differentiation of MSCs along various mesenchymal pathways can be achieved 
by manipulation of the cell culture environment including supplementation of culture 
media with soluble morphogens (Cheng et al. 1994; Indrawattana et al. 2004; Mackay et 
al. 1998; Roelen and Dijke 2003; Worster et al. 2001), modulation of culture substrate 
stiffness (Marklein and Burdick 2010a), and external forces (Guilak et al. 2009; Maul et 
al. 2011).  Of particular interest are environmental approaches which might increase 
differentiation efficiency while reducing upstream bioprocessing costs for the purpose of 
large scale commercial operations.   
 
A predominant challenge of the scaling operations required to process large numbers of 
cells and/or critically sized tissue constructs is the control of nutrient and waste transport 
from the cells/tissues during culture.  To overcome these issues, a number of bioreactor 
concepts have been developed to provide the flow of culture media through (Porter et al. 
2005), across (Saini and Wick 2003), and around the constructs (Bueno et al. 2005; 
Spaulding et al. 1993).  As a result of the media exchange, the constructs are concurrently 
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nourished and exposed to hydrodynamic loading. Shear stress is known to cause varied 
effects on cell populations, including transmembrane ion leakage, as well as physiological 
and metabolic changes.  The presence of fluid shear stress, therefore, is an important 
environmental factor which may play an important role in the stability or instability of the 
MSC phenotype in culture.  Furthermore, if the magnitude and spatiotemporal presentation 
of hydrodynamic loading can be controlled, it may represent a novel approach to 
modulating the efficiency of directed MSC differentiation.  The primary objective of this 
study, therefore, was to determine the effect of uniform shear stress magnitude and duration 
on MSC gene expression through a panel of key differentiation markers along the 
osteochondral differentiation pathway. These genes were selected for their importance in 
orthopedic tissue engineering applications and potential to provide a window into the 
chondrogenic and osteogenic differentiation processes.   
 
Given the well-documented sensitivity of mature chondrocytes and osteoblasts to growth 
factors from the TGF-β superfamily (Roelen and Dijke 2003), a secondary objective of this 
study was to examine the response of MSCs to varying magnitudes of superficial 
hydrodynamic shear stress in cultures supplemented with varying concentrations of TGF-
β3 and BMP-2.  Drawing on evidence that both bone and cartilage are mechanosensitive 
(Papachroni et al. ; Szafranski et al. 2004) and mechanical stimuli are anabolic (Huiskes et 
al. 2000; Jeon et al. 2012), we hypothesized that hydrodynamic loading would increase the 
efficiency of MSC differentiation down the desired pathways as revealed through 
systematic changes in phenotypic markers.  The scope of the study was limited to a range 
of hydrodynamic conditions within the reported interstitial flow regime of bone (Fritton 
and Weinbaum 2009) and cartilage (Mow et al. 1984) with a view to determining an 
optimum for lineage specific differentiation.  Additionally, the growth factor 
concentrations were varied by one order of magnitude in either direction from the most 
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ubiquitous supplementation protocols found in the literature concurrently to determine how 
hydrodynamic culture might minimize their necessity. 
 Materials & Methods 
4.2.1 MSC Isolation 
Bovine bone marrow aspirates were harvested from within the subchondral trabecular bone 
of the femoral condyles of 2–4 week old calves (Research 87, Marlborough, MA).  Isolated 
marrow was mixed with expansion medium (high glucose Dulbecco’s Modified Eagle 
Medium [DMEM] supplemented with 10% certified fetal bovine serum [FBS] and 1× 
penicillin-streptomycin-fungizone [PSF]) supplemented with 300 U/ml heparin), vortexed 
to remove any undesirable fat and bone fragments from the marrow, passed through a 60µm 
cell strainer, and centrifuged to collect cell pellets. Cells were resuspended in the expansion 
medium and plated onto T-75 flasks (Corning, Inc., Corning, NY). After an initial period 
of 24 hours, nonadherent cells were removed from the flasks, whereas adherent cells were 
cultured in expansion medium for an additional 7–10 days until cultures reached 
confluence.  Subsequent subculturing was carried out to Passage 3 at a splitting ratio of 
1:3.  Following Passage 3, MSCs that were suspended in a cryoprotective medium (70% 
DMEM, 20% FBS, 10% dimethylsulfoxide, 1X PSF) at a concentration of 1 million 
cells/mL and stored in liquid nitrogen in 1mL aliquots.   
4.2.2 Assays for Multipotentiality 
Following Passage 1, a portion of MSCs were fixed, treated with a nonspecific blocking 
agent for 30 minutes, and split into six tubes.  Four of the six populations were then 
incubated with one of the following fluorescently tagged antibodies:  fluorescein 
isothiocyanate [FITC]-conjugated mouse anti-human antibodies against each of CD166, 
CD271, and CD45, or R-phycoerythrin [RPE]-conjugated mouse anti-bovine CD44 
antibodies for 1 hour. The remaining two populations were incubated with FITC and RPE 
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conjugated antibodies against mouse IgG as the negative isotype controls.  Flow cytometry 
was performed in a FACScan (BD Biosciences, San Jose, CA). Forward scatter and side 
scatter parameters were used to evaluate the size and granularity of cells, respectively.  
Surface marker analysis was performed following Passage I and then verified again 
following Passage III to insure that spontaneous differentiation had not taken place. 
 
Following confirmation of a consistent set of multipotent cell surface markers, MSCs were 
plated in a 12 well plate at a seeding density of 100,000 cell/well in one of four culture 
media preparations:  expansion media (EM), osteogenic media (OM), adipogenic media 
(AM), and chondrogenic media (CM).  Osteogenic media consisted of high glucose 
DMEM supplemented with 10% FBS, 1X PSF, 100 nM dexamethasone, 10 mM sodium 
β-glycerophosphate, 0.05 mM ascorbic acid.  Adipogenic Media consisted of high glucose 
DMEM supplemented with 10% FBS, 1X PSF, 1 μM dexamethasone, 0.5 mM 
indomethacin, 10 μg/ml insulin, 100 mM 3-isobutyl-1-methylxantine.  Chondrogenic 
Media consisted of high glucose DMEM supplemented with 1× PSF, 0.1 µM 
dexamethasone, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL l-proline, 100 µg/mL sodium 
pyruvate, 1X insulin–transferrin–selenium [ITS], and 10 ng/mL TGF-β3.  Following 21 
days of culture, the monolayers were fixed and assessed for successful induction.  
Osteogenesis was determined by fixing monolayers in isopropanol and staining with 
Alizarin Red for mineralized matrix. Adipogenesis was assessed by fixing with 
paraformaldehyde and staining with freshly prepared Oil Red O to visualize lipid droplets.  
Chondrogenesis was determined by fixing monolayers with 10% formalin and staining 
with Toluidine Blue for an abundance of proteoglycans. 
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4.2.3 Experimental Design 
To elucidate the role of hydrodynamic loading in MSC differentiation towards the 
osteochondral lineages, we selected three magnitudes of fluid shear stress (0 dynes/cm2, 1 
dyne/cm2, 10 dynes/cm2) to be applied in the presence of four levels of growth factor 
stimulation (0 ng/mL, 1 ng/mL, 10ng/mL, 100ng/mL)  for two different growth factors 
(BMP-2, TGF-β3) resulting in 18 experimental groups which received some level of both 
stimuli, 3 groups which received only TGF-β3 stimulation of varying degrees, 3 groups 
which received only BMP-2 stimulation of varying degrees, and 3 unsupplemented groups 
which received only hydrodynamic stimulation of varying degrees.  Samples from each 
experimental group were collected on a weekly basis for 2 weeks.  Additional samples for 
each group were generated at the start of tissue culture (Week 0), but never subjected to 
any of the stated experimental conditions in order to generate a baseline for downstream 
analysis. 
 







100 ng/mL 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
10 ng/mL 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
1 ng/mL 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
Unsupplemented 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
BMP-2 
1 ng/mL 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
10 ng/mL 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
100 ng/mL 0, 1, 10 dynes/cm2 0, 1, 2 Weeks 
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4.2.4 Tissue Culture 
MSCs from three different animals were mixed with sterile agarose solution such that the 
final concentration of MSCs in 2.5% w/w agarose solution was 25 million cells/mL.  
Constructs were then cast into a polydimethylsiloxane [PDMS] mold and cultured either 
statically (0 dyne/cm2) or loaded in a custom flow chamber (Figure 4.1) for dynamic 
culture at one of two wall shear stress (WSS) conditions:  low shear (1 dyne/cm2) or high 
shear (10 dynes/cm2).   To achieve the variation in shear stress at the wall (𝜏𝑤𝑎𝑙𝑙), the 
channel height (h) was varied between two different chamber designs while the kinematic 
viscosity (𝜇), Volumetric Flow Rate, and the channel width (b) were held constant.  This 
approach allowed multiple flow loops from different experimental groups to be driven 
simultaneously by a single, multi-channel peristaltic pump (Masterflex, Cole Parmer, 
Vernon Hills, IL). 
 
 
Figure 4.1:  Illustration of Custom Parallel-Plate Culture System 
Tissue constructs were cultivated utilizing a custom built laminar flow chamber (left).  Two 
separate devices with varying channel heights were produced such that parallel cultures of 




4.2.5 Gene Expression 
Real-time polymerase chain reaction (qRT-PCR) was used to quantify gene expression in 
harvested monolayer cells. Cells were fixed in TRIzol, and RNA was isolated from the 
homogenized cell lysate through a series of rinse, elution, and centrifugation. The RNA 
samples were then reverse transcribed into cDNA using a QuantiTech Rev Transcription 
kit (Qiagen, Hilden, German) according to the manufacturer's protocol. Gene expression 
for target mesenchymal lineage markers was assessed using custom-designed primers 
(Table 1) with quantitative PCR amplification performed on a StepOnePlus™ Real-Time 
PCR System (Applied Biosystems) in the presence of SYBR Green/ROX master mix 
(Applied Biosystems).  GAPDH and β-actin were both used as endogenous controls for 
normalization through geometric averaging.  Relative expression (n=3 per condition and 
time point) of each target gene was calculated according to Equations 4-1 and 4-2 using 
LinReg-PCR, where 𝑁0,𝑖 represents the initial concentration of the target gene, 𝑁𝑞,𝑖 
represents the concentration of the target gene at the threshold, 𝐸𝑖 represents the 
amplification efficiency of the polymerase chain reaction, and 𝐶𝑞 is the selected threshold 
value. 
 
 𝑁0,𝑖 = 𝑁𝑞,𝑖 𝐸𝑖
𝐶𝑞⁄  (4-1) 










⁄  (4-2) 
 
Endogenous controls were evaluated for each experimental group to ensure that their 
expression levels were not significantly altered across time or culture conditions. 
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Table 4.3:  Parameters for Microfluidic Construct Design  




Forward 5’GAGCGGGAAATCGTCCGTGAC 3’ 
Reverse 5’ GTGTTGGCGTAGAGGTCCTTGC 3’ 
GAPDH 
Forward 5' CCTTCATTGACCTTCACTACATGGTCTA 3' 




Forward  5' CATGAAGATGACCGACGAG 3' 
Reverse  5' CGTCTTCTCCGTGTCGGA 3' 
aggrecan 
Forward  5' CACTGTTACCGCCACTTCCC 3' 
Reverse 5' GACATCGTTCCACTCGCCCT 3' 
col2α1 
Forward 5’ ATCCATTGCAAACCCAAAGG 3’ 




Forward 5' CATGCTGCCACAAACAGC 3' 




Forward  5' TTA CAG ACC CCA GGC AGG CAC A 3' 
Reverse  5' TCC ATC AGC GTC AAC ACC ATC A 3' 
osteocalcin 
Forward 5’ TGACAGACACACCATGAGAACCC 3’ 
Reverse 5’ AGCTCTAGACTGGGCCGTAGAAG 3’ 
col1α1 
Forward  5' TGCTGGCCAACCATGCCTCT 3' 
Reverse  5' CGACATCATTGGATCCTTGCA G 3' 
 
4.2.6 Histological Analyses 
For histological analysis, constructs were fixed in 10% buffered formalin, embedded in 
paraffin and sectioned into 8μm thick sections for the midsubstance of the construct.  
Sectioned samples were stained with Toluidine Blue and Alizarin Red per established 
protocols. For immunofluorescence, sections were incubated with a citrate buffer heated to 
99°C for 30 min to retrieve antigens, and allowed to cool to room temperature. The samples 
were then incubated in blocking buffer for 30 minutes and primary rabbit anti-bovine 
antibodies (1:100, Abcam, Cambridge, MA) for Collagen I, II, and X at 4°C overnight. 
Sections were then washed three times in PBS and with DyLight®594 goat anti-rabbit 
secondary antibodies (1:200, Abcam, Cambridge, MA) for one hour at room temperature.  
Finally, samples were washed and mounted with Vectashield with DAPI  and visualized 
on a Nikon Ti Eclipse inverted fluorescence microscope (Nikon Instruments, Inc., Melville, 
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NY), with representative images captured using a CoolSNAP HQ2 CCD camera 
(Photometrics, Tucson, AZ).  
4.2.7 Statistical Analyses 
Independent experiments produced construct samples for RT-qPCR and 
immunohistochemistry (N=3 per group).  For all image analysis of histology specimens, 
the minimum number of images required to accurately represent the whole section were 
used. Gene expression is presented as the mean fold change ± SEM with statistically 
significant differences defined as p < 0.05 using two-way ANOVA with Bonferroni post-




4.3.1 MSC Characterization 
Flow cytometric analysis showed a consistent expression of MSC surface markers (CD166, 
CD271, CD44) while being negative for CD45, a key hematopoietic stem cell marker 
(Figure 4.2), for each of the cell population utilized prior to pooling for experiment.   
 
Figure 4.2:  Expression of MSC Surface Markers 
Adherent cells were lifted from culture after one passaging and test for the presence of 
bovine MSC surface markers consisting of CD271, CD166, and CD44.  Additionally, cells 
were tested for the absence of hematopoietic surface marker CD45.   
 
When these MSCs were subsequently cultured in the presence of inductive media for 3 
weeks, populations cultured in adipogenic, osteogenic, and chondrogenic media deposited 
fat droplets, mineralized matrix, and an abundance of proteoglycans respectively (Figure 
4.3).  These results, taken together, indicate that the population of cells used in this study 
fit the definition of a multipotent mesenchymal stem cells at the onset of tissue culture. 
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Figure 4.3:  MSC Trilineage Induction 
Following confirmation of MSC biomarkers via flow cytometry, MSCs from the bone 
marrow of three calves were pooled, plated, cultured and assessed for tri-lineage 
differentiation potential.  From left to right MSCs culture in inductive media (top) and 
growth media (bottom row) were stained with Oil Red O, Toluidine Blue, and Alizarin Red 
to confirm evidence of adipogenesis, chondrogenesis, and osteogenesis respectively. 
4.3.2 Transcriptome Stability of Unsupplemented Cultures 
In order to control for the effect of hydrodynamic loading on the gene expression profile 
of MSCs, a round of control experiments was performed to assess the stability of the MSC 
transcriptome in unsupplemented, static, three dimensional culture over the course of two 
weeks of cultivation (Figure 4.4).  None of the genes measured exhibited significant 
regulation over the time course of the experiment with respect to the initial expression 
profile, indicating three dimensional culture in isolation of other factors was not a 
significant contributor to differentiation of the MSCs toward the desired lineages and that 
this culture format represents a suitable control for differentiation studies.  This was an 
important realization, as there is evidence in the literature that subtle changes in culture 
conditions, such as the transition from monolayer to three-dimensional culture represented 
here can induce phenotypic changes in stem cell populations (Marklein and Burdick 2010a; 
Marklein and Burdick 2010b; Maul et al. 2011), particularly as a significant contributor to 
chondrogenesis (Bosnakovski et al. 2004).   
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Figure 4.4:  Gene Expression of Unsupplemented Static Cultures 
Gene Expression profiles were determined for unsupplemented, static cultures via RT-
qPCR.  No statistically significant regulation of the genes in the panel was observed. 
 
It is important to note, however, that many of the protocols from the prior art depend on 
pellet culture whereas this study is dependent on the encapsulation of the MSCs in a three 
dimensional agarose hydrogel.  The introduction of the hydrogel material provides 
additional barriers to communication by cell to cell contact, a factor known to play a role 
in chondrogenesis (Tuli et al. 2003), and the deviation of the observations produced 
between these different systems may exist due to the relative differences in cell density 
between the two culture types. It is also noteworthy that the seeding density of the 
constructs was not varied in this study.  It is possible seeding density may also play a role 
in this observation, as prior literature indicates seeding density can have an impact on ECM 
deposition in MSC-based tissue constructs (Huang et al. 2009; Hui et al. 2008).  
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Nevertheless, this observation confirmed the utility of this culture condition as a suitable 
control for our subsequent hydrodynamic culture studies aiming to determine the effect of 
exogenous growth factor supplementation on the mRNA expression profiles of this MSC 
population.    
4.3.3 Effect of Hydrodynamic Loading on Unsupplemented Cultures 
With a suitable control group established, the first step in addressing the potential of 
hydrodynamic loading as a differentiation tool was to culture MSC based tissue constructs 
under laminar flow profiles with nominal shear stress magnitudes of 1 dyne/cm2 and 10 
dynes/cm2 and to compare the expression of a panel of genes spanning the phenotypic 
diversity of cells along the endochondral ossification pathway to the previously discussed 
static controls.  When hydrodynamic culture was introduced as a variable to the three-
dimensional, serum-free cultures (Figure 4.5), no significant regulation of the 
chondrogenic gene panel was observed, significant upregulation of the osteogenic 
transcription factor (RUNX2), and two of the three collagens investigated (COL1Α1 and 
COLXΑ1) occurred under high shear conditions.  RUNX2 and COLXA1 were both 
upregulated early in cultivation (1-week) and remained elevated relative to both the time 
matched static controls and the low shear treatment.   
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Figure 4.5:  Gene Expression of Unsupplemented Hydrodynamic Cultures 
Hydrodynamic loading induced changes in gene expression of several osteochondral 
markers even in the absence of exogenous growth factor supplementation. Genes with 
statistically significant regulation are highlighted with a red box.  Statistically significance 
is indicated by asterisks. 
 
At the 2-week time point, upregulation of COL1A1 was considered significant relative to 
the static cultures.  Interestingly, no significant difference in gene expression was observed 
with lower magnitude hydrodynamic loading, indicating that magnitude of shear in the 
absence in exogenous growth factor supplementation is not inconsequential.  While these 
changes are considered statistically significant, the nominal change in expression of these 
genes was of less than one order of magnitude from the expression profile measured in the 
cell source population.  When compared to the magnitude of impact of growth factor 
supplementation on gene expression when controlled for culture duration (>2 orders of 
magnitude difference), this effect is not likely to be useful as a tool for directed 
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differentiation.  At the same time, however, this finding suggests that great care should be 
taken to minimize the hydrodynamic loading applied to MSC expansion cultures in 
upstream bioprocessing procedures to prevent non-specific induction of undesirable 
phenotypes.   
4.3.4 Effect of Cytokine Supplementation on Differentiation Markers 
While hydrodynamic loading in isolation of exogenous supplementation is not sufficiently 
potent to control differentiation in a selective manner, the results of our initial studies in 
unsupplemented, serum-free cultures suggested that hydrodynamic loading may be useful 
as when presented in concert with morphogens with a known inductive capacity.  To 
investigate this possibility, we analyzed the expression profiles of statically cultured 
constructs which received either TGF-β3 or BMP-2 supplementation at a concentration of 
1 ng/mL, 10 ng/mL, or 100 ng/mL for the purpose of inducing a chondrogenic or 
osteogenic phenotype, respectively.  The resident MSCs tend towards expression of 
chondrogenic markers as function of time in culture and concentration of exogenous 
growth factor supplementation for both BMP-2 and TGF-β3 supplementation.   
 
For TGF-β3 supplemented cultures, the expression of all three chondrogenic markers 
increased significantly relative to the unsupplemented control group for culture durations 
of at least 2 weeks provided the culture media was supplemented with TGF-β3 at a 
concentration of at least 10 ng/mL while differences in expression of the chondrogenic 
markers for cultures supplemented at concentrations lower than 10 ng/mL were not 





Figure 4.6:  Gene Expression of TGF-β3 Supplemented Static Cultures 
TGF-β3 supplementation modulates expression of chondrogenic markers without 
significantly altering the expression profile of the osteogenic panel. Genes with statistically 
significant regulation are highlighted with a red box.  Statistically significance is indicated 
by asterisks. 
 
After two weeks of culture, SOX9 was expressed in a concentration dependent manner as 
the greatest change in expression relative to the source cell population occurred in the 100 
ng/mL supplementation group (667 fold) which was significantly higher than the 10 ng/mL 
supplementation group (145 fold), which in turn was significantly greater than the 1 ng/mL 
supplementation group (12.7 fold).  A similar trend in AGGRECAN and COL2A1 
expression was observed as increases in AGGRECAN expression relative to the source cell 
population was highest in the 100 ng/mL supplementation group (181 fold), which was 
statistically indeterminate from the 10 ng/mL supplementation protocol, but significantly 
higher than 1 ng/mL or lower concentration supplementation protocols.  Likewise, 
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COL2A1 expression reached a maximum among the static cultures when TGF-β3 
supplementation was provided at a concentration of 100 ng/mL (403 fold) for a period of 
two weeks.  Considering the expression of undesirable hypertrophic and osteogenic genes, 
we found comparable mRNA levels among all TGF-β3 supplementation protocols.  
Additionally, the expression level of the hypertrophic and osteogenic markers are 
statistically indeterminate from the unsupplemented controls. 
 
For BMP-2 supplemented cultures, upregulation of genes from both the chondrogenic and 
osteogenic panels at high growth factor concentrations was evident (Figure 4.7).   
 
Figure 4.7:  Gene Expression of BMP-2 Supplemented Static Cultures 
BMP-2 supplementation modulates expression of both chondrogenic and osteogenic 
markers. Genes with statistically significant regulation are highlighted with a red box.  
Statistically significance is indicated by asterisks. 
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When the culture media was supplemented with BMP-2 in concentrations in excess of 10 
ng/mL, the entire chondrogenic gene panel (SOX9, AGGRECAN, and COL2A1) was 
upregulated relative to duration matched cultures receiving BMP-2 supplementation at a 
concentration of 1 ng/mL or less.  Hypertrophic marker COLXΑ1 also showed increases 
with respect to duration matched unsupplemented controls as BMP-2 concentration was 
increased.  Regarding the osteogenic gene panel, OSTEOCALCIN was upregulated in 
cultures supplemented at 10 ng/mL or greater relative to duration matched cultures 
receiving 1 ng/mL or less for each culture period studied. RUNX2 and COL1A1 were also 
upregulated relative to the low supplementation groups (0 ng/mL and 1 ng/mL), but only 
when BMP-2 supplementation was provided at a concentration of at least 100 ng/mL for a 
period of two weeks. 
4.3.5 Effect of Hydrodynamic Loading on Cytokine Supplemented Cultures 
Both BMP-2 and TGF-β3 produced strong differentiation of the MSC population utilizing 
the static culture platform, and provided a baseline for normalization of the 
hydrodynamically loaded cultures to control for the independent effect of the growth 
factors so that we might investigate whether stimulation via hydrodynamic loading can 
induce a synergistic effect on the gene expression profile of the differentiating cell 
population.   
 
BMP-2 supplemented cultures exhibited a strong shear coupling with respect to expression 
of SOX9, RUNX2, and all of the collagens studied, and was strongly biased towards high 
magnitude loading protocols (Figures 4.8-4.10).  It is apparent that RUNX2 was strongly 
upregulated for all BMP-2 supplementation protocols with concurrent high magnitude 
hydrodynamic loading as evidenced by significant increases relative to time-matched static 
controls at each time point investigated as well as significantly high expression relative to 
the low magnitude loading when BMP-2 concentration was at least 10 ng/mL.  In addition 
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to changes in expression of RUNX2, it was also observed that COL1A1 was upregulated 
for the high shear condition groups.  For the 1 ng/mL BMP-2 group, COL1A1 expression 
was significantly higher in the high shear group compared to the static controls at two 
weeks of culture (Figure 4.8).   
 
Figure 4.8:  1 ng/mL BMP-2 Supplemented Hydrodynamic Cultures 
Even at low levels of BMP-2 supplementation, significant regulation of collagens and 
osteochondral transcription factors is observed.  Genes with statistically significant 
regulation are highlighted with a red box.  Statistically significance is indicated by 
asterisks. 
 
When the concentration was raised to 10 ng/mL it was observed that the behavior was 
sustained in addition to being significantly higher than the low magnitude loading group 
as well (Figure 4.9).  When BMP-2 supplementation was provided at a concentration of 
10 ng/mL or lower, there was no significant difference in expression between the static and 
low magnitude hydrodynamic groups for either RUNX2 or COL1A1.   
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Figure 4.9:  10 ng/mL BMP-2 Supplemented Hydrodynamic Cultures 
Transcription factors and collagen modulation is maintained in cultures supplemented with 
10 ng/mL.  Osteocalcin regulation is also observed under high shear conditions, suggesting 
a commitment to the osteogenic differentiation pathway.  Genes with statistically 
significant regulation are highlighted with a red box.  Statistically significance is indicated 
by asterisks. 
 
When BMP-2 supplementation was increased to 100 ng/mL, however, it was observed that 
COL1A1 was significantly upregulated in the low magnitude loading group relative to the 
static control after two weeks of culture (Figure 4.10).  Additionally, hydrodynamic 
modulation of OSTEOCALCIN expression was observed for the first time in these studies 
in the high magnitude loading group relative to the static control after two weeks of culture 
in cultures receiving at least 10 ng/mL of BMP-2. 
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Figure 4.10:  100 ng/mL BMP-2 Supplemented Hydrodynamic Cultures 
When BMP-2 is supplemented at a high level (100 ng/mL) shear stress is a significant 
modulator of all chondrogenic and osteogenic markers studied.  Genes with statistically 
significant regulation are highlighted with a red box.  Statistically significance is indicated 
by asterisks. 
 
Regarding the chondrogenic markers, SOX9 was upregulated in high magnitude loading 
culture relative to the static control for all BMP-2 supplementation groups, but interestingly 
this effect was only considered significant at the 1-week time point.  COL2A1 expression 
was observed to increase in high magnitude hydrodynamic cultures as well, as evidenced 
by significant increases relative to static controls at the 2-week time point for cultures 
receiving 1 ng/mL of BMP-2 and at both time points for culture receiving at least 10 ng/mL 
of BMP-2.  This effect also appears to be sensitive the magnitude of hydrodynamic loading 
as significant difference were observed between the static cultures and low magnitude 
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cultures as well as between the low and high magnitude cultures.  Differences in 
AGGRECAN expression were only considered significant under high shear and high 
supplementation.  It is also worth noting that expression of hypertrophic marker COLXA1 
was significantly increased in the high magnitude loading group after two weeks of culture 
for all BMP-2 supplementation protocols relative to the static control for the low 
concentrations (1 ng/mL) and to both low magnitude and static cultures at elevated 
concentrations of BMP-2 (10 ng/mL and 100 ng/mL). 
 
These results are not terribly surprising in light of the results from unsupplemented, 
hydrodynamically loaded construct group as two osteoinductive agents, hydrodynamic 
loading and BMP-2 supplementation, are at work simultaneously in these protocols.  While 
the slight chondrogenic character of these cultures is not desirable, it is worth noting that 
modulation of chondrogenic markers (SOX9, COL2Α1) at high shear was of less than an 
order of magnitude and the order of the baseline control expression of these genes being 
considerably lower than their osteogenic counterparts.  COLXΑ1 expression increased by 
an order of magnitude over culture period and supplementation matched static controls for 
both low and high shear conditions at two weeks when cultures were supplemented with 
100 ng/mL of BMP-2.  While the inductive impact of hydrodynamic loading is not as great 
in magnitude as that of BMP-2 supplementation at high levels (1 order of magnitude 
change vs 3 orders of magnitude) it none the less is an important modulator of osteogenic 
induction as no significant difference was observed between static cultures supplemented 
at 100 ng/mL and cultures supplemented at 10 ng/mL that were also subjected to high 
magnitude hydrodynamic loading in terms of total gene expression relative to the initial 
MSC population.   
 
When hydrodynamic stimulation was introduced in concert with TGF-β3 supplementation, 
it was observed that COL2A1 was upregulated relative to duration and supplementation 
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group matched controls when the hydrodynamic loading condition was high (10 
dynes/cm2) and TGF-B3 concentrations were low indicating a mild synergistic effect on 
the chondrogenic induction of the resident cell population (Figure 4.11).   
 
 
Figure 4.11:  1 ng/mL TGF-β3 Supplemented Hydrodynamic Cultures 
Hydrodynamic loading has limited impact on MSC based constructs with cultivated with 
low concentrations of TGF-β3 (1 ng/mL).  Modulation of COL2A1 was considered 
significant with high magnitude hydrodynamic loading after two weeks of culture relative 
to time and concentration matched controls.  Noticeably, the regulation of osteogenic genes 
with shear observed in unsupplemented controls disappears.  Genes with statistically 
significant regulation are highlighted with a red box.  Statistically significance is indicated 
by asterisks. 
 
When the supplementation protocol was increased to 10 ng/mL, high shear cultures 
resulted in upregulation of both SOX9 and COL2A1.  No regulation of hypertrophic or 
 65 
osteogenic markers was observed at this supplementation level, and interestingly there was 
no effect on chondrogenic markers in low magnitude hydrodynamic cultures (Figure 4.12).   
 
 
Figure 4.12:  10 ng/mL Supplemented Hydrodynamic Cultures 
TGF-β3 supplementation of 10 ng/mL is the most ubiquitous supplementation protocol for 
chondrogenic cultures found in the literature.  When hydrodynamic loading is introduced 
in concert at these levels of exogenous supplementation, SOX9 and COL2A1 are 
modulated in high shear environments.  Osteogenic markers remain at levels comparable 
to static controls. Genes with statistically significant regulation are highlighted with a red 
box.  Statistically significance is indicated by asterisks. 
 
Upon increasing the TGF-β3 protocol to 100 ng/mL, shear magnitude dependent 
modulation of all three chondrogenic genes studied was observed.  The chondrogenic panel 
was upregulated under high magnitude shear conditions relative to static controls after one 
week of culture and maintained significantly high for subsequent culture durations (Figure 
4.13).  There was no statistical difference between low and high shear conditions for 
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COL2A1 and AGGRECAN expression, but there was a shear magnitude dependency 
observed for SOX9.   
 
 
Figure 4.13:  100 ng/mL Supplemented Hydrodynamic Cultures 
High levels of TGF-β3 supplementation results in strong upregulation of chondrogenic 
genes in the presence of hydrodynamic loading.  Genes with statistically significant 
regulation are highlighted with a red box.  Statistically significance is indicated by 
asterisks. 
 
Interestingly, changes in expression of the osteogenic gene panel were not considered 
significant for any of the hydrodynamic regimes studied.  Expression of COLXΑ1, 
however, was upregulated relative to concentration matched static controls when 
conditions were such that high shear magnitudes (10 dynes/cm2) were paired with low (1 
ng/mL) concentrations of TGF-β3 for a period of at least two weeks.  No significant 
changes in COLXA1 were observed with moderate or high TGF-β3 supplementation.  
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These observations hint at two potentially useful characteristics of this approach.  First, 
chondrogenic differentiation is clearly positively influenced by the presence of 
hydrodynamic loading when presented in concert with at least 10 ng/mL of TGF-β3, and 
that TGF-β3 signaling appears to have an inhibitory effect the on the osteoinductive role 
of high magnitude hydrodynamic loading observed with the other supplementation 
protocols studied herein. 
4.3.6 Histology & Immunofluorescence 
Histological staining and immunofluorescence of two-week culture samples qualitatively 
supports the gene expression profiles observed through PCR (Figures 4.14-4.16).  
Toluidine Blue staining indicates increasing expression of sulfated glycosaminoglycans 
with increases in both BMP-2 and TGF-β3 supplementation, while Alizarin Red staining 
shows greater staining with increased BMP-2 supplementation.  Alizarin Red staining was 
relatively uniform for TGF-β3 supplemented cultures for all hydrodynamic and 
supplementation protocols tested.  Immunofluorescence indicates increasing Collagen type 
I and Collagen type II expression in the BMP-2 and TGF-β3 supplemented cultures of 
increasing concentration respectively.  Trends in collagen expression between shear 
conditions are less clear, but there appears to be more total collagen in BMP-2 






Figure 4.14:  Histologic & Immunofluorescence Staining of Static Cultures 
Histological and Immunofluorescence analyses of static cultures suggest increasing 
osteogenic character with BMP-2 supplementation and increasing chondrogenic character 





Figure 4.15:  Histologic Staining of Low Shear Cultures 
Histological and Immunofluorescence analyses of low shear cultures suggest increasing 
osteogenic character with BMP-2 supplementation and increasing chondrogenic character 





Figure 4.16:  Histologic Staining of High Shear Cultures 
Histological and Immunofluorescence analyses of high shear cultures suggest increasing 
osteogenic character with BMP-2 supplementation and increasing chondrogenic character 







As the predominate source of cells for tissue engineered constructs has shifted from 
terminally differentiated primary cells towards progenitor cells of various differentiation 
potentials, the ability to spatiotemporally exert epigenetic control over the differentiation 
of stem cells within a tissue engineered construct has become desirable as a means to better 
reproduce native tissue complexity and reduce cultivation costs associated with traditional 
differentiation protocols.  Subsequently, we decided to focus herein on the impact of the 
hydrodynamic environment on MSC differentiation due to its essential role in nutrient 
exchange during in vitro cultivation.  Because of this dependency, hydrodynamic loading 
will be an obligate component of any commercial bioprocessing scheme.  The purpose of 
this study was to investigate how modulation of hydrodynamic loading affects the stability 
of the MSC phenotype during serum-free tissue culture and how this approach might 
enhance differentiation efficiency in the presence of growth factors known to be either 
osteoinductive or chondrogenic in nature.  Our primary findings were that hydrodynamic 
loading, in the absence of exogenous supplementation, promotes expression of 
hypertrophic and osteogenic genes.  This observation was sustained for low levels of 
exogeneous supplementation irrespective of the cytokine provided.  Lineage specific 
upregulation towards chondrogenic and osteogenic phenotypes was observed under high 
magnitude shear conditions when hydrodynamic loading was presented in concert with 
high levels of TGF-β3 and BMP-2 supplementation respectively.  Generally, the observed 
impact of hydrodynamic loading on the desired phenotypes was greater in longer term 
cultures, and in cultures receiving higher concentrations of exogenous cytokines.   
 
These findings are in agreement with prior mechanobiological studies in other 
osteochondral lineage cell sources.  In studies based on osteoblastic cell lines, multiple 
studies have shown that hydrodynamic loading is osteopromotive (Bancroft et al. 2002; 
Datta et al. 2006; Grayson et al. 2008; Sikavitsas et al. 2003; Yu et al. 2004), and often 
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results in increases in type I collagen production and matrix mineralization.  Hydrodynamic 
studies on MSCs from various donor species have also been previously shown to be 
osteoinductive (Grellier et al. 2009; Kapur et al. 2003; Kreke et al. 2005)  Additionally, 
multiple studies on primary chondrocytes have shown that in addition to increases in type 
II collagen (Bueno et al. 2008; Gemmiti and Guldberg 2006).  Exposure to high shear 
environments can result in development of a fibrous layer rich in non-hyaline type I 
collagen at shear exposed surfaces (Vunjak-Novakovic et al. 2002), particularly when 
cultured with serum supplemented media (Yang and Barabino 2011) versus serum free 
preparations.  If we compare the extent of the impact of hydrodynamic loading on 
unsupplemented cultures in our study to that of other environmental induction schemes for 
MSCs, we find that the effect on gene expression is on the same order of magnitude as 
manipulations of scaffolding stiffness for osteoinduction (Engler et al. 2006) and both 
hydrostatic pressure (Miyanishi et al. 2006) and dynamic unconfined compressive loading 
(Huang et al. 2010; Huang et al. 2004) for chondrogenic induction .  Unlike these prior 
studies, however, we found the impact of exogenous supplementation on gene expression 
to be considerably greater than the environmental stimulus applied.  Our results converge 
again, however, when the mechanical stimuli were presented concurrently with TGF-β 
supplementation (Huang et al. 2004; Miyanishi et al. 2006).  As in our study utilizing 
hydrodynamic loading, dynamic compression and intermittent hydrostatic loading both 
resulted in additional increases in chondrogenic gene expression when presented in cultures 
supplemented with at least 10 ng/mL.  The order of magnitude of the change, however, is 
considerably greater in our hydrodynamic study (>100 fold change) than either of the prior 
studies utilizing compressive (<10 fold change) and hydrostatic (<10 fold change) loading.    
 
Conversely, other studies have shown compressive loading to have a negative impact on 
glycosaminoglycan accumulation within the construct at the protein level (Campbell et al. 
2006).  It is unclear, however, if this effect is due to decreased synthesis or loss of 
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glycosaminoglycans to the culture media.  Interestingly, the same study (Campbell et al. 
2006), also showed that dynamic compressive loading resulted in increases in COLXA1 in 
the absence of TGF-β supplementation, a result that mirrors our findings of both a 
hypertrophic influence of unsupplemented hydrodynamic loading and of the 
chondroprotective character of TGF-β3 supplementation.  Our findings, herein, seem to 
indicate a comparable role of hydrodynamic loading to that of other environmental factors, 
particularly dynamic compression.  Considering finite element analyses have shown 
interstitial fluid flow to be an effect of dynamic loading in biphasic materials such as those 
referenced herein, it is not surprising that these two loading conditions produce similar 
responses in MSC based tissue constructs. 
 
Our finding that high magnitude hydrodynamic loading promotes osteogenic gene 
expression in unsupplemented cultures is instructive and suggests that MSCs cultures 
intended for chondral therapies not be subjected to high shear hydrodynamic loading 
conditions during processing and cultivation.  It is our recommendation that the nutrient 
utilization of chondrogenic cultures be carefully considered such that fluid loading not be 
applied in excess of magnitudes needed to meet the convective transport demands of the 
tissue.  Conversely, our findings also suggest hydrodynamic loading of osteogenic cultures 
can potentially be a means of either reducing culture dependence on exogenous cytokines 
or promoting increased matrix deposition provided the magnitude of loading is increased 
such that impacts cell viability in a negative manner (Chisti 2001). 
 Conclusions 
The findings of this study bring forth a number of interesting ideas regarding hydrodynamic 
culture of MSC based constructs for tissue engineering applications. As evidenced by 
results from all growth factor supplementation groups, including serum-free expansion 
medium culture, it is clear that MSCs are tuned to their local mechanical loading 
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environment, and that prolonged exposure to high magnitude fluid shear stresses induces a 
hypertrophic phenotype amongst the resident MSCs ultimately resulting in expression of 
osteogenic markers.  For the purpose of chondrogenic cultures, therefore, our results 
suggest minimizing the fluid shear stress imposed on the developing construct without 
reducing the transport of nutrients to all regions of the tissue construct.  Furthermore, this 
phenomenon presents an interesting paradigm for the production of osteochondral tissue 
constructs through differential loading of the construct, both chemically and 
hydrodynamically, by varying the microenvironment appropriately in spatially separated 
regions of the tissue construct.  While to overall goal of the current study of a single media 
source with differential loading to induce phenotypic changes in the MSC population was 
not achieved, there is evidence that loading will play a significant role in bioprocessing 
protocols of osteochondral constructs moving forward as technologies such as microfluidic 
hydrogels (Choi et al. 2007b; Huang et al. 2011; Johann and Renaud 2007; 
Khademhosseini et al. 2006) provide the means to differentially apply chemical and 
environmental cues within an integrated construct of a single cell type to spatially engineer 
osteochondral tissues for intra-articular injury repair and preclinical models for 
pharmacological studies against osteoarthritis. 
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5 SPATIAL ENGINEERING OF OSTEOCHONDRAL TISSUE 
CONSTRUCTS THROUGH MICROFLUIDICALLY DIRECTED 
DIFFERENTIATION OF BOVINE MESENCHYMAL STEM 
CELLS 
 Introduction 
The development of engineered tissue grafts has emerged as a promising therapeutic 
alternative for the repair and replacement of organs.  A number of approaches, employing 
a diverse spectrum of scaffolds, cell populations, and bioprocessing conditions have been 
pursued for the production of such grafts, and most of these efforts have focused on 
engineering homogenous tissues with bulk properties similar to their native counterpart.  
Some tissues, however, are heterogeneous both structurally and functionally, and possess 
spatially-varying biochemical compositions and mechanical properties for which the use 
of a single scaffolding material, cell source, or bioreactor chamber may be inappropriate. 
A classic example of this is the osteochondral unit, consisting of a hyaline cartilage layer 
and the integrated subchondral bone.  Osteochondral defects resulting from traumatic 
injury are typically treated through a grafting technique termed mosaicplasty.  One of the 
primary shortcomings of mosaicplasty is the reliance on autologous graft sourcing from a 
healthy, non-load bearing site that is both limited in its availability and potentially 
inappropriate for repair due to advanced osteoarthritic degeneration.  To address this supply 
issue, a number or approaches have been pursued to create a suitable replacement for the 
autologous grafts.  Common approaches to recapitulate the unique heterogeneity of the 
osteochondral unit include the production of homogeneous and composite scaffoldings 
loaded with one or more cell sources having chondrogenic and/or osteogenic potential, and 
cultivating them utilizing both commercially available and custom built bioreactor 
systems.  Constructs produced in this manner, however, are still non-optimal as they suffer 
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from a number of shortcomings.  Arguably the most pertinent shortcoming of these 
approaches are their reliance on terminally differentiated cells (osteoblasts and 
chondrocytes) isolated from patient specific biopsies and expanded in vitro.  Use of these 
cells is plagued by the same dependency on an available autologous donor site as well as 
low proliferation rates and potential degradation of functionality should in vitro expansion 
be necessary to sufficiently populate the tissue engineered construct.   
 
Mitigation of this particular shortcoming may be accomplished by utilizing an 
undifferentiated, multipotent mesenchymal stem cells as a single autologous cell source for 
repair of osteochondral defects.  MSCs are well known progenitor cells for both the 
chondrocyte and osteoblast lineages which have been used to generate osteochondral 
constructs using single-component or composite scaffolds across a range of compositions 
and material properties (Bal et al. 2010; Bi et al. 2011; Cui et al. 2011; Gao et al. 2001b; 
Ghosh et al. 2008; Haasper et al. 2008; Hung 2003; Lima et al. 2004; Martin et al. 2007; 
Scotti et al. 2007; Sherwood et al. 2002; Swieszkowski et al. 2007; Taguchi et al. 2004).  
The primary challenge to MSC based constructs, arises from the need to either utilize costly 
predifferentiation operations prior to the seeding of the construct or simultaneously 
modulate differentiation down to distinct lineages in a unified culture solution.  Using 
conventional bioreactor systems, the popular approach of supplementing the culture media 
with lineage specific signaling molecules to achieve directed differentiation of MSC is 
untenable for biphasic constructs without some means of spatially directed delivery to 
prevent dominance of one desired phenotype throughout the construct.   
 
Based on these realities, we hypothesized that the spatially confined presentation of 
optimized differentiation cues would result in tissue-specific biological environments for 
the regeneration of both bone and cartilage tissues using a model universal donor cell 
source in an integrated tissue construct.  To test this hypothesis, we utilized a microfluidic 
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hydrogel platform previously developed in our lab to stimulate region specific induction of 
osteoblastic and chondrogenic phenotypes through parallel, independent microfluidic 
networks, and evaluated the constructs after two weeks of culture for the presence of 
gradients in gene expression and matrix composition. 
 Materials & Methods 
Unless specified otherwise, supplies and reagents were purchased from VWR International 
(West Chester, PA), Sigma (St. Louis, MO) or Invitrogen (Carlsbad, CA). Antibodies were 
from AbD Serotec (Raleigh, NC) or Abcam (Cambridge, MA).  ELISA kits for Collagens 
I and II were purchased from Chondrex, Inc. (Redmond, WA) and for Collagen X from 
MyBioSource, Inc. (San Diego, CA). 
5.2.1 MSC Isolation & Characterization 
Bovine bone marrow aspirates from 2–4 week old calves (Research 87, Marlborough, MA) 
was isolated and mixed with expansion medium (high glucose Dulbecco’s Modified Eagle 
Medium [DMEM] supplemented with 10% certified fetal bovine serum [FBS] and 1× 
penicillin-streptomycin-fungizone [PSF]) supplemented with 300 U/ml heparin), subjected 
to vortexing and straining processes to remove any undesirable tissues prior to cell pelleting 
and collection via centrifugation. Following centrifugation, cells were resuspended in fresh 
expansion medium and plated onto T-75 flasks (Corning, Inc., Corning, NY). Nonadherent 
cells were removed from the flasks during media change after 24 hours, whereas adherent 
cells were cultured with the EM for an additional 7–10 days until confluence.  Subsequent 
subculturing was carried out to Passage 3 at a splitting ration of 1:3.  Following Passage 3, 
MSCs that were suspended in a cryoprotective medium (70% DMEM, 20% FBS, 10% 
Dimethylsulfoxide [DMSO]) at a concentration of 1 million cells/mL and stored in liquid 
nitrogen in 1mL aliquots.   
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MSCs from Passages 1-4 were plated in a 12 well plate at a seeding density of 100,000 
cell/well in one of four culture media preparations:  expansion media (EM), osteogenic 
media (OM), adipogenic media (AM), and chondrogenic media (CM).  Osteogenic media 
consisted of high glucose DMEM supplemented with 10% FBS, 1X PSF, 100 nM 
dexamethasone, 10 mM sodium β-glycerophosphate, 0.05 mM ascorbic acid.  Adipogenic 
Media consisted of high glucose DMEM supplemented with 10% FBS, 1X PSF, 1 μM 
dexamethasone, 0.5 mM indomethacin, 10 μg/ml insulin, 100 mM 3-isobutyl-1-
methylxantine.  Chondrogenic Media consisted of high glucose DMEM supplemented with 
1× PSF, 0.1 µM dexamethasone, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL l-proline, 
100 µg/mL sodium pyruvate, 1X insulin–transferrin–selenium [ITS], and 10 ng/mL TGF-
β3.  Following 21 days of culture, the monolayers were fixed and assessed for successful 
induction.  Osteogenesis was determined by fixing monolayers in isopropanol and staining 
with Alizarin Red for mineralized matrix. Adipogenesis was assessed by fixing with 
paraformaldehyde and staining with freshly prepared Oil Red O to visualize lipid droplets.  
Chondrogenesis was determined by fixing monolayers with 10% formalin and staining 
with Toluidine Blue for an abundance of proteoglycans. 
 
MSCs from Passages 1-4 were fixed, treated with a nonspecific blocking agent for 30 
minutes, and split into six tubes.  Four of the six populations were then incubated with one 
of the following fluorescently tagged antibodies:  fluorescein isothiocyanate [FITC]-
conjugated mouse anti-human antibodies against each of CD166, CD271, and CD45, or R-
phycoerythrin [RPE]-conjugated mouse anti-bovine CD44 antibodies for 1 hour. The 
remaining two populations were incubated with FITC and RPE conjugated antibodies 
against mouse IgG as the negative isotype controls.  Flow cytometry was performed in a 
FACScan (BD Biosciences, San Jose, CA). Forward scatter and side scatter parameters 
were used to evaluate the size and granularity of cells, respectively. 
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5.2.2 Tissue Culture 
Microfluidic constructs were prepared as described previously.  Briefly, construct molds 
were produced by casting polydimethylsiloxane (PDMS) against micromachined acrylic 
molds and curing the polymer at 90°C for 90 minutes following degassing under vacuum.  
On Day 0 of tissue culture, the surface of the PDMS molds were rendered hydrophilic via 
oxygen plasma and autoclaved before construct fabrication by casting a 25 million cell/mL, 
2.5% agarose solution, between the acrylic casings and the PDMS molds (Figure 5.1).  A 
planar slab of the cell-agarose solution was then sealed between the two molded portions 
to complete the construct as depicted in Figure 5.1. 
 
 
Figure 5.1:  Assembly of Microfluidic Osteochondral Constructs 
Construction process of the microfluidic osteochondral graft. Each target region is 
independently cast and controlled via ports in the acrylic casing.  The chondrogenic and 
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osteogenic regions are separated by a planar midsubstance region molded directly into a 
PDMS gasket which ensures unidirectional flow through the microfluidic networks. 
 
Constructs were connected to independent flow loops through which media was 
recirculated via a syringe pump equipped with dual check valves to achieve unidirectional 
flow and culture commenced under regionally specific bioprocessing conditions.  Within 
the control group, EM was supplied to both microfluidic networks of the construct at 
constant perfusion at a volumetric flow rate of 250 μL/min.  The prescribed flow rate was 
selected to both fulfill the minimal flow rate requirements for the nutrient demands of the 
resident cell population as previously determined, and to provide a uniform shear stress 
distribution of 1 dyne/cm2 at the microchannel walls in the central region of interest.  
Constructs from the experimental group received two different sets of bioprocessing 
conditions.  The osteogenic region was provided with EM supplemented with 10 ng/mL 
BMP-2 at a constant perfusion rate of 2.5 mL/min such that the shear stress distribution at 
the microchannel walls was a uniform 10 dyne/cm2.  The chondrogenic region was supplied 
with EM supplemented with 10 ng/mL TGF-β3 at a the same flow rate as the control group 
so as to produce a uniform 1 dyne/cm2 shear stress distribution at the microchannel wall.  
A gas exchange reservoir was connected to the flow loop and a 5% CO2 mixture bubbled 
through the culture media to maintain pH.  Total culture media volume was maintained at 
100mL with fresh media exchanges were performed every 3-4 days through sampling ports 
attached to the gas exchange reservoir. 
5.2.3 Gene Expression Analysis 
Real-time polymerase chain reaction (qRT-PCR) was used to quantify region specific gene 
expression within the constructs. Constructs were fixed in TRIzol, and RNA was isolated 
from the homogenized cell lysate through a series of rinse, elution, and centrifugation 
processes. The RNA samples were then reverse transcribed into cDNA using a QuantiTech 
Rev Transcription kit (Qiagen, Hilden, German) according to the manufacturer's protocol. 
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Gene expression for target mesenchymal lineage markers using custom-designed primers 
(Table 1) with quantitative PCR amplification performed on a StepOnePlus™ Real-Time 
PCR System (Applied Biosystems) in the presence of SYBR Green/ROX master mix 
(Applied Biosystems).  GAPDH and β-actin were both used as endogenous controls for 
normalization through geometric averaging.   
5.2.4 Biochemical Analysis 
To determine the biochemical composition of the construct layers, assays were performed 
to determine the proteoglycan, DNA, and collagen content. Samples were first weighed 
wet and digested for 16 h in papain at 60ºC. Aliquots were analyzed for sulfated 
glycosaminoglycan (sGAG) content using the 1,9-dimethylmethylene blue dye-binding 
assay, for DNA content using the PicoGreen dsDNA Quantification kit (Molecular Probes, 
Eugene, OR),  and for collagen types I, II, and X by ELISA. 
5.2.5 Histological Analysis 
For histological analysis, constructs were fixed in 10% buffered formalin, embedded in 
paraffin and sectioned into 8μm thick sections for the midsubstance of the construct.  For 
immunofluorescence, sections were incubated with a citrate buffer heated to 99°C for 30 
min to retrieve antigens, and allowed to cool to room temperature. The samples were then 
incubated in blocking buffer for 30 minutes and primary rabbit anti-bovine antibodies 
(1:100, Abcam, Cambridge, MA) against collagens type I, II, X at 4°C overnight. Sections 
were then washed three times in PBS and treated with DyLight®594 goat anti-rabbit 
secondary antibodies (1:200, Abcam, Cambridge, MA) for one hour at room temperature.  
Finally, samples were washed and mounted with Vectashield with DAPI  and visualized 
on a Nikon Ti Eclipse inverted fluorescence microscope (Nikon Instruments, Inc., Melville, 
NY), with representative images captured using a CoolSNAP HQ2 CCD camera 
(Photometrics, Tucson, AZ).  
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5.2.6 Statistical Analysis 
Sample sizes for RT-qPCR and Immunohistochemistry were N=3 each.  Sample Sizes for 
biochemical analyses were N=5 each.  For all image analysis of histology specimens, the 
minimum number of images required to accurately represent the whole section were used. 
Bar graphs are presented as the mean ± SEM with statistically significant differences 
defined as p < 0.05 using two-way ANOVA with Bonferroni post-hoc tests for multiple 
comparisons. 
 Results 
5.3.1 Cell Proliferation 
As depicted in Figure 5.2, there was no significant difference in DNA content between the 
osteogenic and chondrogenic regions of either the control group or experimental group 
osteochondral tissue constructs. 
 
Figure 5.2:  DNA Content of Microfluidic Osteochondral Constructs 
After two weeks of culture DNA content was significantly higher in the experimental group 
which received cytokine supplementation relative to the unsupplemented control group.  
There were no significant differences between the various regions of the experimental 
cultures. 
 
Additionally, the midsubstance region between the two microfluidic networks was not 
found to be significantly different from either of the target regions for either the control or 
experimental groups.  There was, however, a statistically significant difference in DNA 
content between the control and experimental groups across all phenotypic regions of the 
tissue constructs after two weeks of culture.   
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5.3.2 Differential Expression of Osteochondral Genes 
Looking first at the control group, there is no difference in the osteogenic (RUNX2, 
OSTEOCALCIN, and COL1Α1), hypertrophic (COLXΑ1), or chondrogenic (SOX9, 
AGGRECAN, and COL2Α1) gene expression profiles between the various regions of the 
tissue constructs.  Within the experimental group, however, differential expression of both 
the osteogenic and chondrogenic gene expression profiles with respect to the opposing 
construct region was observed.   
 
Figure 5.3:  Differential Gene Expression of Osteochondral Constructs 
Differential loading of an osteochondral tissue construct results in gene expression 
gradients of both osteogenic and chondrogenic genes 
 
Considering first the osteogenic target region, a statistically significant upregulation of 
RUNX2 and COL1Α1 was observed within the osteogenic target region relative to the 
chondrogenic target region.  Regulation of the osteogenic gene panel was also greater than 
 84 
that of the chondrogenic panel with the exception of aggrecan, but not in a statistically 
significant manner.  With regard to the chondrogenic gene panel, a statistically significant 
regulation of the entire chondrogenic gene panel (SOX9, AGGRECAN, and COL2Α1) 
within the chondrogenic region relative to the osteogenic target region of the construct.  
Additionally, COLXΑ1 expression was observed to increase across the construct from the 
chondrogenic regions to the osteogenic region, with a statistically significant difference in 
expression occurring between the chondrogenic and osteogenic regions, but no with such 
difference occurring between the midsubstance and osteogenic regions. 
 
5.3.3 Glycosaminoglycan Content 
As evidenced by the results of the DMMB assay, glycosaminoglycan content was 
significantly higher in the experimental group relative to the control group (Figure 5.4).   
 
Figure 5.4:  sGAG Content of Osteochondral Constructs 
Measurement of sulfated glycosaminoglycan content within the various regions of the 
osteochondral constructs by DMMB assay reveals significantly higher sGAG 
accumulation in the experimental group irrespective of the construct region relative the 
control group.  Within the experimental group, however, no statistically significant 
difference was observed. 
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Within the experimental group, however, no statistically significant regulation of sGAG 
was observed although the maximum value was observed within the chondrogenic region 
while the minimum value was observed within the osteogenic region. 
5.3.4 Graded Collagen Composition 
ELISA was performed for expression of collagens Type I, II, and X.  As depicted in Figure 
5.5, all three collagen types exhibited graded expression across the construct, with types I 
and X exhibiting their maximum concentration in the osteogenic target region of the 
construct and type II exhibiting a maximum concentration in the chondrogenic region of 
the construct.  It is worth noting that the magnitude of collagen types II is considerably 
greater than that of type I, even in the osteogenic region of the experimental constructs.  
Within the control group, collagen content is significantly lower with no gradations of note. 
 
Figure 5.5:  Differential Collagen Content of Osteochondral Constructs 
ELISA reveals gradients in Collagen type I across the osteochondral constructs, and 
differential expression of collagen types II and X between the osteogenic and chondrogenic 
regions of the experimental group.  
 
5.3.5 Histology & Immunofluorescence 
Control constructs stained weakly and relatively homogeneously for both histological 
stains and for all collagens tested following two weeks of culture.  The experimental group, 
however, exhibited much stronger staining across all regions.  Within the experimental 
group, Toluidine Blue staining revealed no discernible difference in proteoglycan content 
between the various regions of the osteochondral constructs.  Alizarin Red staining 
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revealed a slight gradient in mineralization with a region of high concentration within the 
osteogenic layer and a region of low concentration in the chondrogenic layer.  Collagen 
staining revealed a mild gradient in both type I and type II collagen with the highest 
concentration of each located within the osteogenic and chondrogenic layers respectively.  
Collagen X staining results were inconclusive. 
 
Figure 5.6:  Histology & Immunofluorescence of Osteochondral Constructs 
Immunofluorescence staining shows gradients in collagen types I and II.  Alizarin Red 





The purpose of the study described herein was to evaluate microfluidic hydrogels as a 
platform for the production of osteochondral tissue constructs through the spatially directed 
differentiation of bovine mesenchymal stem cells.  The ability of the mechano-chemical 
inductive cues provided through the microfluidic networks to direct zone-specific 
differentiation was evaluated through gene expression analysis, biochemical composition, 
and histological staining. Relative to our non-inductive control cultures, the spatially 
defined presentation of inductive factors and bioprocessing conditions had a clear impact 
in proliferation of the resident cell population and elaboration of a spatially discrete 
osteochondral matrix within our experimental group.  On a whole construct basis, 
differences between the control and experimental constructs included significant increases 
in both DNA content and total osteochondral matrix elaboration.  These findings are in 
agreement with the prior literature on the effects of the TGF-β superfamily proteins 
provided to these cultures (Massague 1990; Wozney 1992) as well as to previous findings 
from our group on the synergistic effects of hydrodynamic loading on MSC differentiation 
efficiency in the presence of these factors.  Within the experimental group, there was 
evidence of spatial differences in matrix composition reminiscent of the osteochondral 
junction. The chondrogenic target region of the construct showed a local maximum of 
glycosaminoglycan content and significantly higher expression of Collagen II relative to 
the osteogenic target region, while significantly higher expression of Collagen I and X was 
observed in addition to a minimum in glycosaminoglycan content in the osteogenically 
targeted region of the constructs.  Additionally, Alizarin Red staining showed an increase 
in mineralization within the osteogenic region.  The dual presence of sGAG and 
mineralization within the osteogenic region indicates the concurrent formation of both 
cartilage and bone, and may represent an intermediate differentiation step along the 
endochondral ossification pathway for the culture period studied herein, rather than a 
terminal bone phenotype.  While suboptimal, we believe this result to be an acceptable for 
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the culture durations studied and hypothesize that cultivation for longer durations would 
replacement of the cartilaginous portion of the matrix with higher quality bone formation 
(Wang et al. 1990; Wozney 1992).  This is further supported by the relatively lower 
presence of both Collagen I and mineralization in the chondrogenic region indicating this 
endochondral bone formation is concentrated near the BMP-2 supply network and that the 
cartilage formation in the chondrogenic region is hyaline in character.   
 
For the purpose of benchmarking our technology, there are various reports utilizing dual 
culture control systems for osteochondral tissue engineering are present in the literature 
that warrant discussion.  Chang et al cultured a gelatin infused sinbone block to generate 
osteochondral constructs in a dual-chambered bioreactor approach that validated their 
scaffolding system for the production of hyaline cartilage within the gelatin portion of the 
composite scaffolding (Chang et al. 2004).  The bony portion of this scaffold however 
acellular in nature.  Mahmoudifar and Doran used a similar dual chambered bioreactor to 
that implemented by Chang et al for the production of osteochondral tissue constructs from 
two sutured together polyglycolic acid meshes seeded with adipose derived stem cells 
(Mahmoudifar and Doran 2013).  This approach mirrored our results after two weeks of 
culture with respect to statistically indeterminate differences in glycosaminoglycan content 
between the layers, but did not find differential expression of collagen II as we report 
herein.  Compared to these studies our constructs are not only cellularized in both the 
osteogenic and chondrogenic regions as was also show by Mahmoudifar and Doran, but 
our system was also shown to suppress osteogenic character within the chondrogenic layer.  
While the characteristics of the cell type seeded in each of these systems may also play a 
role in the improvement shown with respect to this metric, we believe the improvement is 
due to improved controlled of the microenvironment provided by the presence of the 
microfluidic network within the tissue construct versus the superficial delivery of inductive 
cues characteristic of the dual chambered bioreactor.  While more challenging to 
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implement than the simple elegance of the dual chambered bioreactor, the paradigm 
proposed by our system also offers the capability to produce thicker constructs as necessary 
and even greater optimization of culture conditions by the incorporation of more 
independent microfluidic networks into the construct. 
 Conclusions 
In this study, we have established a paradigm for the production of biphasic tissue 
constructs through microfluidically directed differentiation of mesenchymal stem cells 
using the osteochondral unit as a model tissue.  While there is evidence in the literature of 
other approaches to spatially engineer the composition of an osteochondral construct, this 
study is the first of its kind to utilize microfluidic networks to successfully engineer a 
biphasic tissue of clinically relevant thickness with measurable differences in biochemical 
composition between the bony and cartilaginous regions.  The results presented herein 
highlight how optimized mechano-chemical microenvironment can affect the production 
of tissue specific extracellular matrix of the resident cell population seeded in the various 
regions of a hydrodynamically loaded osteochondral construct compared to control 
constructs produced through a non-inductive bioprocessing scheme.  Based on our results, 
we believe that this approach may have significant potential for the production of a number 
of interfacial tissues including tendon, ligament, and of course the osteochondral unit for 
use in regenerative capacities.  We would be remise, however, if we did not address the 
dependency of the ultimate utility of this approach on the further development of enabling 
material and biofabrication technologies to help achieve cost effective production and 
processing of well-defined, robust tissue products.  In light of this the need for future 
research in these areas, we believe these results of this study represent an important first 
step in the rational design of engineered osteochondral units through establishment of a 
platform for the future optimization of scaffolding formulations and bioprocessing 
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parameters towards the production of commercially viable osteochondral tissue products 
using microfluidic scaffolding strategies. 
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6 FUTURE DIRECTIONS  
The work described herein represents a significant advancement of microfluidic 
scaffolding platforms for the production of engineered tissue grafts.  As a result, these 
findings also warrant further development of the technology for clinical translation, and 
the development of engineered tissues as models for preclinical pharmacology studies.  The 
microfluidic platform developed herein is perfectly situated as a scaffold-bioreactor hybrid 
to fulfill any or all of these potential purposes due to its flexibility in terms of customization 
with a few strategic improvements to weaknesses in its current implementation.   
6.1.1 Further Investigation of Fluid Shear Effects in Scaffolding Material 
The shear stresses reported in these studies refer only to the expected shear stress at the 
construct surface (Chapter 4) or the microchannel wall (Chapters 3 and 5).  Within the 
porous scaffolding material, however, a boundary layer will develop in which pore-level 
flow exists, but the magnitude of the shear stress experienced by the embedded cells is 
heterogeneous and likely considerable lower than the nominal values reported herein.  
Additionally, the magnitude of the shear experienced will decrease with distance from the 
hydrodynamically loaded surface.  Additional studies in which detailed measurements of 
these shear values as a function of distance from the tissue surface would provide valuable 
insight into the role of hydrodynamic loading on the biological processes occurring in the 
tissue constructs developed herein. 
6.1.2 Longer Term Culture Periods 
While the extension of cultivation of microfluidic based tissue constructs to two weeks is 
one of the many achievements accomplished in these studies, there would be great value 
in extended the cultivation period even further to reach the order of months.  Longer 
cultivation times would likely result in better approximation of the native mechanical 
properties due to increased matrix elaboration in both the chondral and osteochondral tissue 
 92 
constructs and increased calcification of the bony portion of the osteochondral constructs.  
Further, longer cultivation periods would better approximate the time period necessary to 
produce a functional tissue product, and thus provide greater insight into how to best 
optimize the construct for commercial implementation. 
6.1.3 Further Optimization of Cellular Microenvironment 
6.1.3.1 Cell Seeding Density 
While the impact of cell seeding density was studied from a mathematical standpoint with 
respect to nutrient utilization within a microfluidic tissue construct, in vitro evaluation of 
microfluidic construct development was only carried out at one cell seeding density.  It is 
well established that the cells which constitute a tissue communicate with each other 
through both physical contact and paracrine delivery of chemical signals.  At low cell 
seeding densities, it is likely that the increased distance between neighboring cells will 
have an impact on the physiology of the cells involved due to reduced communication and 
increased or otherwise disrupted timing of paracrine signaling.  At increased cell seeding 
densities is likely that increased cell-to-cell contact will result in increased communication 
between cells that would likely have a measurable impact on cellular metabolism and/or 
differentiation.  A study which modulates the seeding density within the microfluidic 
scaffolding system described herein could potential provide valuable information for the 
further optimization of the microfluidic constructs for the production of tissue engineered 
cartilage or osteochondral grafts.  Such a study would be easy to implement using the 
bioprocessing guidelines suggested in Chapter 3 of this dissertation, and potentially offers 
the opportunity to investigate the role of cellular communication at densities much higher 
than previously reported for tissue engineering applications due to the mass transport 
advantages offered by the presence of the microfluidic network. 
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6.1.3.2 Cellular Substrate Stiffness 
It is well established that the stiffness of the substrate to which a cell is attached can have 
an impact on cellular processes including metabolism, proliferation, migration, and 
differentiation.  In the studies described herein the stiffness was not addressed as a variable 
for differentiation, providing an opportunity for further optimization of MSC laden 
microfluidic hydrogel systems.  Following the approach of Tse and Engler (2010) the 
stiffness of cellular substrate stiffness can be controlled by modulating the cross-linking 
density of polymeric substrates (Tse and Engler 2001).  Utilizing this approach, Engler et 
al. varied the elasticity of a polyacrylamide substrate from 0.1 to 40 kPa and showed 
differentiation of MSCs toward neural, myogenic, and osteogenic lineages, with neural 
expression occurring at the lowest substrate stiffness and osteogenic differentiation 
occurring on the most stiff substrates (Engler et al. 2006).  Further, Park et al. showed that 
substrate stiffness in combination with TGF-β supplementation was capable of modulating 
differentiation of MSCs between smooth muscle cell and chondrogenic phenotypes.(Park 
et al. 2011) with chondrogenic phenotypes occurring at lower substrate stiffnesses than that 
of the smooth muscle cell.  These findings together indicate that spatially varying the 
stiffness of the hydrogel within our microfluidic platform between a lower value in the 
chondrogenic region and a higher value in the osteogenic region may provide an additional 
induction signal to further optimize differentiation efficiency within our osteochondral 
grafts.  Implementing such a study in our current, agarose based system would require 
increasing the weight fraction of the agarose gel, and adjusting the microchannel spacing 
and culture media flow rates accordingly as defined in Chapter 3 of this dissertation.  
Greater control over substrate elasticity, however, would be achieved in a synthetic 
hydrogel material, so it might be more advantageous to pursue a change of material system 
prior to pursuing such studies. 
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6.1.3.3 Presentation of Biomimetic Features 
While naturally occurring polymers are often used as scaffolding materials for tissue 
engineering, synthetic polymers lack inherent biological functionality. They may facilitate 
protein absorption, but such non-specific interactions occur spontaneously and are not 
controllable. Subsequently, the tethering of molecules to influence cellular processes such 
as adhesion, migration, or signaling represents an additional design space for the 
optimization of the cellular microenvironment.  This approach relies on the choice of 
highly functional monomers that exhibit at least one site for the conjugation of a protein, 
peptide, or drug in addition to the polymerization groups.  Additionally, the permanence or 
release profile of the conjugated bioactive molecule can be tailored to the intended purpose 
(i.e. adhesion, signaling, etc.).  Utilizing this approach it may be possible to further increase 
the induction efficiency of MSCs within a microfluidic construct.  For instance, both TGF-
β  and dexamethasone have been conjugated to PEG based tissue constructs for the purpose 
of inducing chondrogenesis (McCall et al. 2012) and osteogenesis (Nuttelman et al. 2006) 
respectively.  Particularly in the case of dexamethasone, it may be beneficial to increase 
the concentration within the osteogenic region through conjugation rather than media 
supplementation as it is a smaller molecule than TGF-β3 and BMP-2 studied herein, and 
would likely diffuse more readily across the midsubstance region.  Additionally, molecules 
such as the RGD peptide are commonly utilized in synthetic scaffolds to provide 
attachment sites and cell signaling via integrins, both of which would have been shown to 
enhance chondrogenic and osteogenic differentiation (Re’em et al. 2010; Yang et al. 2005).   
6.1.3.4 Use of Oxygen Tension as a Chondrogenic Differentiation Cue 
Hypoxic Environments are well established as a chondrogenic differentiation cue in the 
literature.  As such, control of oxygen tension within the independent microfluidic 
networks of the osteochondral constructs represents an additional variable that may be 
manipulated within the system developed herein to drive chondrogenesis and osteogenesis 
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in a differential manner.  The expected outcome of such studies would be presentation of 
low levels of dissolved oxygen within the chondrogenic region relative to the osteogenic 
region would result in additional gains in chondrogenic gene expression and improved 
cartilaginous matrix deposition in the chondrogenic region relative to the osteogenic 
region.  Impact on the osteogenic region in such a setup is expected to be minimal. 
 
6.1.4 Improvements to Fabrication Processes 
Perhaps the greatest weakness of the microfluidic scaffolding strategy presented herein is 
related to the technical, time consuming nature of its fabrication and reliance on a skilled 
operator.  The fabrication is both time sensitive and susceptible to failure due to 
misalignment and delamination leading to material waste.  Recent advances in the field of 
additive manufacturing offer a potential solution to this problem.  As additive processes 
produce geometries by building up three-dimensional structures based on thin layers of two 
dimensional patterns they are well suited for building microfluidic networks into hydrogels 
in a robust and highly reproducible manner.  Ideally, the scaffolding material should permit 
application of novel additive manufacturing technologies, so that a microfluidic construct 
with any desired 3-D geometry can be designed and fabricated using various medical 
imaging modalities.  Additive manufacturing technologies produce parts by manipulating 
source materials in several possible ways: thermal, chemical, mechanical and/or optical 
(Melchels et al. 2012). Among the state of the art additive manufacturing modalities most 
suitable for hydrogel systems, thermal and chemical setting methods are most commonly 
utilized in mechanical rastering systems, while optical methods are more commonly 
utilized in large area methodologies.  Optical methodologies typically offer advantages 
with respect to spatial resolution and production time over other methods, particularly those 
which utilize a digital mirror device to expose entire layers at once.  Further, thermal and 
chemical methods may be inappropriate for the purpose of cell encapsulation if glass 
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transition temperatures, pH levels, or free radical concentrations drastically exceed 
physiological levels.   
 
The encapsulation of cells during a layered manufacturing build that is based on optical 
methods is also non-trivial as localized heating and free radicals produced during 
photopolymerization can result in cell death.  For UV based approaches, UV exposure is 
known to have a direct negative impact on cell viability. Further, given the layer-by-layer 
nature of additive manufacturing technologies, the encapsulated cell population is expected 
to experience repeated UV doses in a depth dependent fashion. Therefore, it is paramount 
to minimize these effects and often by optimizing exposure times and photoinitiator 
concentrations. 
 
Ultimately, any practical implementation of microfluidic scaffolding technologies with 
require an additive manufacturing approach to limit the weaknesses of the platform 
developed in this dissertation.  Further, the automated nature of these tissue assembly 
technologies makes them more scalable, reproducible, and controllable which will make 
tissue production cheaper, more customizable, and less dependent on the technical 
capabilities of the operator.  
6.1.5 Incorporation of Features to Promote Integration 
Even the most structurally, mechanically, and biochemically optimized tissue engineered 
construct will fail to function in vivo if the construct fails to integrate with the host tissue 
defect.  Immobilization of the construct within full thickness chondral defects can be 
enhanced by incorporation of subchondral bone into the construct.  The relatively rapid 
remodeling of subchondral surrounding the construct and ultimate integration with the host 
tissue provides quicker fixation of the construct within the defect (Khan et al. 2008).  
Subsequently, lateral integration of the slower remodeling cartilage tissue may therefore 
be enhanced in the vertically constrained construct. With respect to osteochondral grafts, 
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it has been postulated that the incorporation of the subchondral bone layer helps serve to 
improve vertical integration in vivo due to the increased remodeling rates present in bone 
relative to cartilage.  Lateral integration of the graft with the native chondral tissue, 
however, is often neglected from a construct design perspective.  As the scope of this 
dissertation was limited to the in vitro development and validation of the technology, 
innovative construct fixation features were not implemented herein, and represent an 
opportunity for further development.  One logical approach to address lateral integration 
would be in add an integration lattice to outer surface of the tissue construct, that would 
provide increased access for infiltration of the surrounding tissue, and increased surface 
area for cell attachment and the introduction of frictional forces associated with neotissue 
elaboration.  This approach will require improvements in the fabrication processes as 
previously discussed and special attention to detail near the fluidic ports to ensure the 
absence of leaks. 
6.1.6 Assessment of In Vivo Performance 
Within this dissertation, great consideration has been taken to carefully engineer tissue 
constructs with the goal of achieving comparable functional properties relative to the native 
tissue.  This technology, however, cannot be fully evaluated without analysis of the graft 
function in vivo.  Further to be commercially viable, the tissue engineered graft must not 
simply repair the articular surface, it must also produce better long-term joint function than 
would be expected if the injury was treated utilizing standard of care.  For case of 
osteochondral grafts such as those developed herein, the most accessible load bearing 
animal model is that of the New Zealand White Rabbit.  Using this model, experimental 
chondral and/or osteochondral grafts are press fit into a surgically produced full thickness 
defect and allowed to integrate with the native tissue for a predetermined period of time.  
Surgical control treatments can be introduced on the contralateral limb so that direct 
comparisons within the same individual can be made with respect to integration, viability, 
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and function.  Assessing microfluidic osteochondral constructs, produced either as 
described herein or with one or more of the suggested improvements described above, 
using the New Zealand rabbit model is the logical next step in assessing microfluidic 
hydrogel technologies for clinical translation. 
6.1.7 Microfluidic Constructs for Pharmacological Studies 
While the use of the microfluidic constructs developed in this dissertation for therapeutic 
purposes is still far from clinical implementation, use of this system for the development 
of model tissues for preclinical pharmacological studies is another route that may be more 
tractable in terms of making an impact on treatment strategies for intra-articular injuries in 
the near term.  Traditionally, drug discovery has been carried out in monolayer cultures 
which do not mimic the extracellular environment and cell-cell communication engineered 
tissue models can provide.  Further, these 2D cultures are also carried out statically, which 
greatly limits the ability of the investigator to study physiological responses to gradients or 
dynamic presentation of the investigational drug.  The microfluidic platform developed in 
this dissertation, however, is capable of achieving both of these key factors, and may 
provide more robust data to support fast tracking key compounds for clinical studies.  
Further, most human pharmacokinetic response data is predicted using expensive animal 
models.  If this costly step in drug development could be reduced or eliminated by utilizing 
human tissue models, the total cost to market of future drugs could be drastically reduced.  
Finally, the ability to connect multiple units in series allows for the study of multiple organ 
system models to be included in the model to detect how an osteoarthritis drug candidate 
may impact other critical systems such as the liver.  I believe this application for 
microfluidic tissue engineering strategies will continue to experience increased interest in 
the coming years and represents another great opportunity for further development of 
microfluidic tissue constructs. 
  
 99 
7 FINAL THOUGHTS 
Tissue engineering has the potential to eliminate the supply and demand, donor matching, 
and disease transmission issues associated with standard osteochondral allografts by 
providing highly characterized functional grafts upon demand.  To achieve this lofty goal, 
the tissue engineering community will have to continue to develop more sophisticated tools 
for robust construct fabrication and manufacture. My particular approach, in spite of its 
inherent weaknesses, provides an excellent model for the rational design of tissue 
constructs of moderate spatial complexity and for studying their development over the 
course of weeks. 
 
In addition to laying out the framework for the design of microfluidic tissue constructs and 
developing the bioprocessing methods for their cultivation, these studies advance our 
understanding of the in vitro hydrodynamic conditions of the cellular microenvironment 
and how they interact with the chemical environment to bring about changes in construct 
composition. The findings that high magnitude hydrodynamic loading of MSC-laden tissue 
constructs both enhances the expression of tissue specific genes in inductive cultures and 
osteogenic gene expression in non-inductive cultures are both important for the future 
translation of tissue engineered technologies.  As hydrodynamic loading is ubiquitous in 
protocols requiring convective transport, these findings will be key for developing 
bioprocesses which reduce waste, minimize media supplementation costs, and achieve 
consistent results necessary to meet the quality standards for commercial success. 
 
Finally, achieving functional tissue constructs will require recapitulating and controlling 
their spatial complexity.  Our studies in Chapter 5 represent one approach towards this end.  
By differentially loading our microfluidic constructs both physically and chemically, I was 
able to modulate matrix composition in a spatially defined manner from a single progenitor 
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cell type.  As alluded to in Chapter 6, there are a myriad of other mechanisms by which the 
differentiation efficiency of MSCs can be positively influenced.  Achieving further 
increases in functional properties of osteochondral tissue constructs, or any other spatially 
complex tissue, such that they adequately replicate those of the native tissue will require 
expansion of the insights gained through this work regarding the tightly controlled 
presentation of inductive clues and the further development of enabling technologies in 




APPENDIX A:  MASS TRANSPORT PROPERTIES OF AGAROSE  
A.1.1.1. Literature Review of Solute Diffusion Coefficients in Agarose 
When developing an immobilized cell system, such as the agarose based tissue constructs 
utilized in this dissertation, it is important to understand the transport properties of the 
scaffolding material for the types of solutes intended to interact with the cells contained 
within.  In the studies described in this dissertation, the primary solutes of interest are 
glucose, bone morphogenic protein 2 (MW= 16 kDA), and transforming growth factor beta 
3 (MW=25kDA).  Therefore, we review herein the literature describing the experimentally 
determined diffusion coefficients of a range of biomolecules within tissue engineered 
constructs which might approximate the transport characteristics of our system. 
 








2.9% Agarose Glucose 0.18 6.70E-06 Mignot 1990 
2.0% Agarose Dextran (10kDa) 10 8.50E-07 Albro 2009 
2.0% Agarose Lactalbumin 14.2 1.14E-06 Saltzman 1994 
2.0% Agarose Ovalbumin 45 7.80E-07 Saltzman 1994 
2.0% Agarose BSA 66.5 6.40E-07 Saltzman 1994 







































































































As is evident in Tables A.1-A.3 above, the diffusivity of solutes in both agarose based 
tissue construct and articular cartilage tends to decrease with solute molecular mass and 
the presence of cells and extracellular matrix.  Also based on the studies in cell-free 
agarose, there does not appear to be a considerable difference in diffusivity between linear 
and globular macromolecules.  As TGF-β3 (25 kDa) is the largest molecule studied herein, 
it represents the case for which the static constructs will most slowly reach equilibrium 
with the surrounding culture media.  Based on the studies referenced in the tables above, 
the diffusivities of BMP-2 and TGF-β3 in the 2.5% agarose gels utilized in this dissertation 
are likely between 10-5 and 10-7 cm2/s.  Perhaps the most relevant values are provided in 
Table A.2 for the MSC seeded agarose systems under chondrogenic cultures.  The data 
from these specific cultures were fit to a power law relationship of the form y=Ax-B with 
diffusivity on the y-axis and molecular mass on the x-axis to provide a best estimate for 
the diffusivities of BMP-2 and TGF-β3 of 4.3e-6 cm2/s and 3.4e-6 cm2/s respectively.  
Incorporating these values into the solution for the time constant of 1-D diffusion into a 
semi-infinite body (Equation A.1) along with the characteristic length of diffusion in our 
constructs (L=425 µm) provides estimated diffusion constants of 1.8 and 2.2 minutes for 







Provided that changes in gene expression were measured on a weekly basis, or 
approximately 4500 times longer than the time required for the solutes to reach equilibrium 
in the static cultures, it is likely that the changes in gene expression measured in Specific 
Aim II are in fact the result of constant hydrodynamic loading through culture and not due 
to convective transport. 
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A.1.1.2. Experimental Validation of Modeling Parameters 
A.1.1.2.1. Theoretical Basis  
For the system described herein, the microfluidic channel spacing was designed for the 
conservative case of interstitial transport via diffusion alone.  I assume, however, that the 
effect of fluid shear stress at the nominal boundary of the microfluidic channel is ‘felt’ by 
the cells encapsulated within the hydrogel scaffolding.  To validate this assumption, the 
concentration of a fluorescent tracer within was monitored using a microscope and image 
grabber for a period of time.  The intensity of the resulting images was averaged across the 
height of the region of interest and fit an analytical solution of the 1-D advection diffusion 











To match the experimental conditions, the initial condition of zero concentration 
everywhere is applied: 
𝐶(𝑥, 0) = 0 
After time t=0, the concentration at x=0 is set to a constant concentration (𝐶0 ) equal to the 
concentration in the source fluid.  Given these conditions, the solution for x>0 is given 
(Equation A2): 
 














Using this solution, we are able to determine an effective diffusivity for two separate 
experimental conditions:  static (diffusion-only) and dynamic (Poiseuille flow in the 
microchannel).  When compared to each other the experimental value for the effective 
diffusivity under dynamic conditions should be lower than the static condition due to the 
presence of convective transport.  If the experimentally determined diffusivity is entered 
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as a constant in Equation 2 when evaluating the images for the dynamic experiments, it is 
possible to determine a pore-level velocity for each discrete value of x.  Using these values 
and a simple open pore hydrodynamic model, we can estimate the pore-level fluid shear 
stress magnitude experienced by the encapsulated cells. 
A.1.1.2.2. Experimental Setup 
To experimentally determine the validity of our assumptions regarding mass transport and 
fluid flow within the agarose based constructs utilized in this dissertation, a FITC labeled 
70 kDa dextran was introduced at a concentration of X mg/mL into a single microfluidic 
channel of 425 µm x 425 µm square cross section sealed against a microscope slide.  Upon 
introduction of the tracer into the , a series of images was captured once every minute for 
a period of one hour using an inverted microscope and a CoolSNAP HQ2 CCD camera 
(Photometrics, Tucson, AZ).  Images were then analyzed for fluorescence intensity as a 
function of distance from the edge of the microchannel and time using a custom algorithm 
implemented in MATLAB. 
A.1.1.2.3. Image Processing Algorithm 
The Image Processing Algorithm utilized in this analysis is summarized in the flow chart 




Figure A.1:  Image Processing Algorithm for Mass Transport Measurements 
 
To reduce the complexity of the analysis, the experimental system was intended to mimic 
one dimension transport into a semi-infinite planar body.  To transform the two 
dimensional nature of the experimental system, each image was first imported into the 
MATLAB workspace as an M x N matrix of intensity values representing each pixel.  The 
intensity data was then passed through an averaging process in which the column values 
were averaged to produce a 1 x N vector representing the one-dimensional transport for 
each frame of the time series. Once each frame was reduced to a 1xN vector, the data from 
the first frame captured after introduction of the tracer was placed through a thresholding 
process to establish the edge of the channel as the origin of a one-dimensional coordinate 
system based on prior calibration of the microscope objective.  Intensity Values were then 
normalized to the average fluorescence intensity within the microchannel, and mapped to 
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a similarity variable of the form 𝜂 = 𝑥 2√𝑡⁄  where x is the distance from the edge of the 
microchannel and t is the time elapsed between introduction of the tracer and the time of 
image capture. A least squares regression of the mapped intensity values were fit to the 
solution for one-dimensional mass transport into a semi-infinite planar body (Equation 
A2).  As the velocity and diffusivity values are yet determined, the diffusion only (u=0) 
studies were fit to determine an estimate of the diffusivity.  The dynamic studies were then 
analyzed using regression analysis to receive an estimate of the interstitial flow velocity. 
A.1.1.2.4. Results 
Model constructs were filled with 50 ng/mL of 70kDA FITC-labeled dextran, and filmed 
either under perfusion or hydrostatically.  A truncated time series of the tracer is illustrated 
in Figure A.2 below:  
 
Figure A.2:  Sample Time Series of Dispersion Measurements 
 
Dispersion of the tracer was analyzed as described above, and the dispersion coefficients, 




Figure A.3:  Experimentally Determined Dispersion Coefficients 
 
Prominent finding from these studies include the observation that our diffusion 
measurements are in close agreement with the value predicted by the Mackie-Mears 
relationship, and that the presence of flow in the microchannel increases the dispersion of 
our tracer solution by two orders of magnitude, indicating the presence of convective 
transport within the porous medium of the agarose construct. 
A.1.1.2.5. Discussion 
Dispersivity is a parameter that characterizes the dispersion of solutes due to convective 
transport in porous media.  Factors which influence dispersivity in include the size of the 
solute, the porosity of the material, temperature, tortuosity of the porous network, and the 
viscosity of the fluid.  As the viscosity, solute size, and temperature were all unchanged in 
our experiments, we seek a relationship between the dispersivity and the physical 
properties of the porous media to obtain an estimate of the average pore-level velocity in 
our system.  The dispersion coefficient is related to the effective diffusivity as follows 
(Equation A.4), where 𝐸 is the dispersion coefficient,  𝐷𝑒𝑓𝑓 is the effective diffusivity, 𝜍 is 
the dispersivity, and 𝑢 is the pore-level velocity. 
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 𝐸 = 𝐷𝑒𝑓𝑓 + 𝜍𝑢 (A.4) 
 
If we our choice of channel spacing as a characteristic value of the dispersivity in agarose 
gels, the estimated average pore-level velocity for our system is 14 µm/s (0.3% of average 
channel velocity), which is in line with measurements from other laboratories (Chen et al. 
2012) and estimates of interstitial flow velocities in articular cartilage in vivo (Mow et al. 
1980), and seems reasonable even if our estimate of dispersivity was off by an order of 




APPENDIX B:  BIOCHEMICAL PROTOCOLS 
 PAPAIN DIGESTION  
Reagent  
1) 35mg Cysteine  
2) 20ml PBE  
3) 0.lml Papain enzyme  
Procedure  
1) Add 35mg cysteine in 20ml PBE  
2) Filter sterilization  
3) Add 0.lml papain enzyme 
4) Place 1ml of solution into each Eppendorf tube  
5) Place in 60°C water bath for 17 hours  
6) Store at -20°C (short term ~ 1 year) or -70°C (long term)  
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PICOGREEN DNA ASSAY 
Reagents  
1) Dilute 20X tris-EDTA solution to 1X with deionized water.  
2) PicoGreen working solution  
a. Mix 100 μL of PicoGreen stock solution with 19.9 mL of diluted tris-
EDTA buffer.  
b. Protect working solution from light using aluminum foil. 
c. The solution is stable for 1 day.  
3) DNA working standards  
a. Dilute 30 μL of Lambda DNA standard with 1.47 mL of diluted tris-
EDTA buffer (DNA stock solution: 2 μg/mL).  
b. Prepare the working standards based on the table below: 






1000 0 2 
500 500 1 
300 700 0.6 
100 900 0.2 
10 990 0.02 
1 999 0.002 
0 1000 0 
 
Procedure  
7) Dilute samples and controls with diluted tris-EDTA buffer (dilution factor = 
1:60 ~ 1:120).  
8) Add 100 μL of working standards, diluted samples and controls to each well of 
a 96-well plate in duplicate.  
9) Add 100 μL of PicoGreen working solution to each well.  
10) Incubate the plate in the dark at room temperature for 5 minutes.  
11) Read the plate using a fluorescence plate reader with an excitation wavelength 
of 480 nm and an emission wavelength of 520 nm.  
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DMMB BLUE ASSAY 
Reagents 
1) DMMB dye solution  
a. Add 16 mg of DMMB to 5 mL of 100% ethanol and mix the solution 
for at least 12 hours until the DMMB is fully dissolved.  
b. Mix the dissolved DMMB solution with 950 mL of deionized water, 8.7 
mL of 1 N hydrogen chloride, 3.04 g of glycine and 2.367 g of sodium 
chloride.  
c. Adjust pH to 3.0 using 1 N hydrogen chloride or sodium hydroxide. 
d. Thoroughly mix using a stir bar.  
e. Measure the absorbance of the DMMB dye solution using a 
spectrophotometer.  
i. 0.30 < A525 < 0.34  
ii. 1.25 < A592 < 1.33  
1. If the readings are too high, dilute the dye solution with 
deionized water.  
2. If the readings are too low, add one grain of DMMB to 
the dye solution and stir it for 12 hours.  
3. Re-measure the absorbance.  
f. Store in the dark for up to 3 months.  
 
2) PBS-EDTA-cysteine solution  
a. Dissolve 0.372 g of EDTA and 0.175 g of cysteine in 100 mL of PBS. 
b. The solution is stable for 1 day.  
3) Chondroitin sulfate working standards  
a. Dissolve 50 mg of chondroitin sulfate in 10 mL of PBS-EDTA-cysteine 
solution (chondroitin sulfate solution: 5 mg/mL).  
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b. Mix 2 mL of chondroitin sulfate solution with 48 mL of PBS-EDTA-
cysteine solution (chondroitin sulfate stock solution: 200 μg/mL).  
c. Prepare the working standards based on the table below (Table A.2).  
Chondroitin sulfate 





0 1000 0 
125 875 25 
250 750 50 
375 625 75 
500 500 100 
625 375 125 
750 250 150 
875 125 175 
1000 0 200 
 
Procedure  
1) Dilute samples and controls with PBS (dilution factor = 1:15 ~ 1:50).  
2) Add 8 μL of working standards, diluted samples and controls to each well of a 96-
well plate in duplicate.  
3) Add 200 μL of DMMB dye solution to each well.  
4) Incubate the plate at room temperature for 2 minutes.  
5) Read the plate using a spectrophotometer at 525 nm.  





1) Assay stock buffer  
a. Dissolve 25.217 g of monohydrate citric acid and 60 g of sodium acetate 
trihydrate in 423.17 mL of deionized water.  
b. Add 6 mL of acetic acid, 70.83 mL of 6 N sodium hydroxide and 5 drops 
of toluene to the solution.  
2) Assay working buffer  
a. Mix 10 mL of deionized water, 15 mL of isopropanol and 50 mL of 
assay stock buffer together.  
b. Adjust pH to 6.0 using 1 N hydrogen chloride or sodium hydroxide.  
c. Store at room temperature for up to several months.  
3) Chloramine-T solution  
a. Mix 2 mL of deionized water, 2 mL of isopropanol and 16 mL of assay 
working buffer together.  
b. Dissolve 0.282 g of Chloramine-T in the mixture.  
c. Store in the dark at 4˚C for up to 1week.  
4) pDAB solution  
a. Dissolve 3 g of pDAB in 12 mL of isopropanol.  
b. Add 5.2 mL of 60% perchloric acid slowly.  
c. Add 2.8 mL of n-propanol to the mixture.  
d. The solution is stable for 1 day.  
5)  Hydroxyproline working standards  
a. Dissolve 10 mg of hydroxyproline in 100 mL of deionized water 
(hydroxyproline stock solution: 100 μg/mL).  











0 1000 0 
100 900 10 
200 800 20 
300 700 30 
400 600 40 
500 500 50 
600 400 60 
700 300 70 
800 200 80 
900 100 90 
1000 0 100 
 
Procedure  
1) Take 120 μL of working standards, samples and controls and place them in 
glass test tubes.  
2) Add 120 μL of 12 N hydrogen chloride to each tube and vortex.  
3) Cover the tubes with marbles and incubate them at 100˚C for 3 hours, followed 
by an 18-hour incubation at 95˚C using an oven in a fume hood.  
4) Cool samples at room temperature.  
5) Re-suspend the dried standards, samples and controls in 1 mL of deionized 
water and vortex.  
6) Dilute samples and controls with deionized water (dilution factor = 1:2 ~ 1:10).  
7) Add 50 μL of standards and diluted samples and controls to each well of a 96-
well plate in duplicate.  
8) Add 50 μL of chloramine-T solution to each well and incubate the plate in the 
dark at room temperature for 20 minutes.  
9) Add 50 μL of pDAB solution to each well and incubate the plate in water bath 
at 60˚C for 30 minutes.  
10) Cool the plate at room temperature for 15 minutes.  
11) Read the plate using a spectrophotometer at 550 nm.  
12) Assume a ratio of hydroxyproline to total collagen of 1:10.  
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COLLAGEN I ELISA 
(ADAPTED FROM CHONDREX, INC.) 
Reagents 
 
1) Type II Collagen Standard 1 vial 100 µl, 100 µg/ml -20°C 
2) Capture Antibody 1 vial 100 µl, 5 mg/ml -20°C 
3) Detection Antibody 1 vial Lyophilized -20°C 
4) Solution A - Capture Antibody Dilution Buffer 1 bottle 10 ml -20°C 
5) Solution B - Sample/Standard Dilution Buffer 1 bottle 50 ml -20°C 
6) Solution C - Detection Antibody Dilution Buffer 1 bottle 10 ml -20°C 
7) Solution D - Streptavidin Peroxidase Dilution Buffer 1 bottle 20 ml -20°C 
8) -20°C 
9) OPD 2 vials Lyophilized -20°C 
10) Chromagen Dilution Buffer 1 bottle 20 ml -20°C 
11) Stop Solution - 2N Sulfuric Acid 1 bottle 10 ml -20°C 
12) Wash Buffer, 20X 1 bottle 50 ml -20°C 
13) ELISA Plate 1 each 96-well (8-well strips x 12) -20°C 
Procedure 
1) Add Capture Antibody: Dilute one vial of Capture Antibody with 10 ml of 
Capture Antibody Dilution Buffer (Solution A). Add 100 ml of capture 
antibody solution to each well and incubate at 4°C overnight. 
2) 2. Dilute Wash Buffer: Dilute 50 ml of 20X wash buffer in 950 ml of distilled 
water (1X wash buffer). Wash the plate with 1X wash buffer at least 3 times 
using a wash bottle with manifold or an automated plate washer. Empty the 
plate by inverting it and blot on a paper towel to remove excess liquid. Do not 
allow the plate to dry out. 
3) Prepare Standard Dilutions: The recommended standard range is 3.125-200 
ng/ml. Prepare serial dilutions of the standard by mixing 20 ml of 100 mg/ml 
standard with 980 ml of Sample/Standard Dilution Buffer (Solution B) - 2000 
ng/ml. Then mix 100 ml of the 2000 ng/ml standard with 900 ml of Solution B 
- 200 ng/ml. Then mix 250 ml of the 200 ng/ml standard with 250 ml of Solution 
B - 100 ng/ml. Then repeat this procedure to make five more serial dilutions of 
standard - 50, 25, 12.5, 6.25, and 3.125 ng/ml solutions. The 100 mg/ml 
standard stock may be stored at -20°C for use in a second assay. We recommend 
making fresh serial dilutions for each assay.  
4) Prepare Sample Dilutions: Dilute tissue samples 1:1-1:1000 with Solution B 
depending on the estimated collagen content in the samples. Cell samples can 
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be used without further dilution. However, if it is necessary, dilute cell samples 
1:1-1:100 with Solution B. 
5) Add Standards and Samples: Mix samples and standard tubes well. Add 100 ml 
of Solution B (blank), standards and samples to appropriate wells. Incubate at 
room temperature for 2 hours.  
6) Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle 
with manifold or an automated plate washer. Empty the plate by inverting it and 
blot on a paper towel to remove excess liquid. Do not allow the plate to dry out. 
7) Add Detection Antibody: Dissolve one vial of Detection Antibody in 10 ml of 
Detection Antibody Dilution Buffer (Solution C). Add 100 ml of detection 
antibody solution to each well and incubate at room temperature for 2 hours. 
8) Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle 
with manifold or an automated plate washer. Empty the plate by inverting it and 
blot on a paper towel to remove excess liquid. Do not allow the plate to dry out. 
9) Add Streptavidin Peroxidase: Dilute one vial of Streptavidin Peroxidase in 10 
ml of Streptavidin Peroxidase Dilution Buffer (Solution D). Add 100 ml of 
streptavidin peroxidase solution to each well and incubate at room temperature 
for 1 hour. 
10) Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle 
with manifold or an automated plate washer. Empty the plate by inverting it and 
blot on a paper towel to remove excess liquid. Do not allow the plate to dry out. 
11) OPD: Dissolve one vial of OPD in 10 ml of OPD Dilution Buffer just prior to 
use. Add 100 ml of OPD solution to each well immediately after washing the 
plate. Incubate for 30 minutes at room temperature. 
12) Stop: Add 50 ml of 2N sulfuric acid (Stop Solution) to each well.  
13) Read Plate: Read the OD values at 490 nm. If the OD values of samples are 
greater than the OD values of the highest standard, re-assay the samples at a 
higher dilution. A 630 nm filter can be used as a reference. 
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APPENDIX C:  HISTOLOGY & IMMUNOHISTOCHEMISTRY 
 SAFRANIN-O AND FAST GREEN STAINING 
Procedure 
Protocol Step Reagent Time (min : sec) 




02 : 00 
3 Distilled water 05 : 00 
4 0.2% aqueous fast green 01 : 00 
5 1% acetic acid 00 : 03 
6 0.5% safranin-O 05 : 00 
7 95% alcohol 01 : 00 
8 100% alcohol 01 : 00 
9 100% alcohol 01 : 00 
10 100% alcohol 01 : 00 
11 Xylene substitute 01 : 00 
12 Xylene substitute 01 : 00 
13 Xylene 01 : 00 
 
Results  




Reagent Preparation  
1) 1. Sodium citrate solution  
a. Dissolve 2.94 g of sodium citrate in 1 L of deionized water.  
b. Adjust pH to 6.0 using 1 N hydrogen chloride or sodium hydroxide.  
c. Add 500 μL of 20X PBS/Tween-20 solution.  
d. Store at room temperature for 3 months or at 4˚C for longer storage.  
2) Blocking buffer  
a. Mix 150 μL of (goat) serum with 10 mL of PBS.  
3) Diluted primary and secondary antibodies  
a. Mix primary antibodies with blocking buffer at a desired ratio.  
Deparaffinization/Rehydration: 
1) Wash three times in xylene for 5 min each. 
2) Wash two times in 100% ethanol for 10 min each. 
3) Wash two times in 95% ethanol for 10 min each. 
4) Rinse sections two times in dH2O for 5 min each. 
Antigen Retrieval 
1) Bring slides to a boil in 10 mM sodium citrate buffer pH 6.0, then maintain at 
a sub-boiling temperature for 10 min. Cool slides on bench top for 30 min. 
Staining Procedure  
1) Block specimen in blocking buffer for 60 min. 
2) While blocking, prepare primary antibody by diluting in blocking buffer to 
desired concentration 
3) Aspirate blocking solution, apply diluted primary antibody. 
4) Incubate overnight at 4°C. 
5) Rinse three times in 1X PBS for 5 min each. 
6) Incubate specimen in fluorochrome-conjugated secondary antibody diluted in 
antibody dilution buffer for 1–2 hr at room temperature in the dark. 
7) Rinse three times in 1X PBS for 5 min each. 
8) Coverslip slides with DAPI doped mountant. 
9) For best results, allow mountant to cure overnight at room temperature. For 
long-term storage, store slides flat at 4°C protected from light. 
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APPENDIX D:  QUANTITATIVE RT-PCR PROTOCOLS 
RNA ISOLATION 
Reagents 
1) TRIzolR Reagent and PureLink™ RNA Mini Kit (included) 
2) • Chloroform or 4–Bromoanisole 
3) • 96-100% ethanol and 70% ethanol (in RNase-free water) 
Procedure 
1) Homogenize tissue samples in 1 ml TRIzolR Reagent per 50–100 mg tissue 
using a tissue homogenizer or rotor-stator. The sample volume should not 
exceed 10% of the volume of TRIzolR Reagent used for homogenization. 
2) Phase Separation 
a. Incubate the lysate with TRIzolR Reagent (previous page) at room 
temperature for 5 minutes to allow complete dissociation of 
nucleoprotein complexes. 
b. Add 0.2 ml chloroform or 50 μl 4–Bromoanisole per 1 ml TRIzolR 
Reagent used. Shake the tube vigorously by hand for 15 seconds. 
c. Incubate at room temperature for 2–3 minutes. 
d. Centrifuge the sample at 12,000 × g for 15 minutes at 4°C. 
e. Transfer ~400 μl of the colorless, upper phase containing the RNA to 
a fresh RNase–free tube. 
f. Add an equal volume of 70% ethanol to obtain a final ethanol 
concentration of 35%. Mix well by vortexing. 
g. Invert the tube to disperse any visible precipitate that may form after 
adding ethanol. 






Reagents and Supplies 
1) Purified RNA 
2) RNase, DNase-free water 
3) Corning half area UV 96-well plates (VWR 33501-012)  
 
Protocol 
1) In each well of the UV plate, add 5 µL of purified RNA and 170 µL of water 
such that the dilution factor (D) is 35. 
2) Add 175 µL of water to additional wells as the negative control (or blank). 
3) Take absorbance readings at 260-nm, 280-nm and 320-nm lights. 
4) Purity of isolated RNA can be calculated using the following equation: (the 





5) Quantity of RNA can be calculated using the Beer’s Law with 1-cm pathlength 
of light: 
𝑢𝑔 𝑅𝑁𝐴 = {𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑠𝑎𝑚𝑝𝑙𝑒(𝐴260) − 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑏𝑙𝑎𝑛𝑘(𝐴260)} × 40 × 𝐷





Reagents and Supplies  
1) Purified RNA  
2) QuantiTect Rev. Transcription Kit – 200 reactions (Qiagen 205313, -20°C)  
Protocol  
1) Thaw purified RNA and the RT kit on ice.  
2) Mix each solution and centrifuge briefly to collect residual liquid from the sides 
of the tubes, and store on ice.  
3) Prepare the genomic DNA (gDNA) elimination reaction on ice based on the 
following table:  
Component 




gDNA wipeout Buffer, 7X 2 μL 1X 
RNA Variable (1 ng – 1 μg)  
RNase-free water Variable  
Total 14 μL  
 
4) Incubate the mixture at 42°C for 2 min and place immediately on ice.  
5) Prepare the RT master mix on ice according to the following table:  
Component 




Reverse transcriptase 1 μL  
RT Buffer, 5X 4 μL 1X 
RT primer mix 1 μL  
Total 6 μL  
 
6) Add 6 μL of RT mix to each of 14 μL of gDNA elimination tube from step 3 
and result in a volume of 20 μL in total.  
7) Mix and store on ice.  
8) Incubate the mixture at 42°C for 15 min followed by 3 min of incubation at 
95°C to inactivate the reverse transcriptase.  
9) Store cDNA samples at -80°C.  
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POLYMERASE CHAIN REACTION 
1) Thaw cDNA, primers and the SYBR Green kit on ice. 
2) Mix each solution and centrifuge briefly to collect residual liquid from the sides 
of the tubes, and store on ice 
3) Prepare PCR master mix on ice based on the following table: 
 
Component Volume/Reaction (well) Final Concentration 
SYBR Green, 2X 10 µL 1X 
RNase-free water 3 µL  
10 µM forward primer 2 µL 1 µM 
10 µM reverse primer 2 µL 1 µM 
Total 18 µL  
 
4) Load 2 µL of cDNA or water (blank, negative control) into each well and add 
18 µL of PCR master mix to each well and mix by pipetting up and down.  
(Total Volume= 20 µL) 
5) Cover the plate with optical film and proceed to thermocycler. 
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LINREQ PCR PROTOCOL 
1) Export the uncorrected amplification data from the thermocycler to Excel 
2) Read data into LinReg-PCR: 
a. Select Step-One Plus (ABI) and DNA binding dye (SYBR Green). 
b. Select the columns and rows which hold the amplification data. 
3) Setup Analysis for single stranded cDNA data with no baseline correction 
4) Run baseline determination analysis 
5) Check each sample to examine efficiencies and exclude poorly amplified 
samples as necessary 
6) Set the log (fluorescence) threshold value on the left. 
a. Note: Make sure to keep this consistent between all plates with the same 
gene. 
b. Note: In StepOne, the threshold fluorescence is usually less than 1, 
which is why the log (fluorescence) value in LinRegPCR is negative. 
7) Save this data to Excel. 
8) Organize and perform Data Reduction in Excel 
a. Use geometric means when averaging data. (Taking the geometric mean 
is the same as taking the arithmetic mean of the cycle thresholds.) 








10) Calculate a manual ∆∆ method; that is, divide a sample’s gene’s starting 
concentration by the sample’s housekeeping gene concentration, then divide by 
the geometric mean of your negative control. 
11) Perform statistical analysis on the negative control normalized values. 
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